rfhg_89937.1

Basic information about the TSS

---

TSS ID: rfhg_89937.1 Species: human Chr: chr6		Start: 163414599 End: 163414630 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3928383,EH38E2522719)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000453779.6:13 ENST00000275262.11:13 ENST00000392127.6:13 AB067799:13 AB067800:13 AB067801:13 AB067798:13 GeneID: 9444 HGNC/MGI_ID: HGNC:21100 UniProt_ID: Q96PU8 Nearer transcript ids and distances: ENST00000361752.8:88 NM_001301085.2:88 NM_006775.3:88 NM_206853.3:88 NM_206854.3:88 NM_206855.3:88 AF272349:131 view more...

Gene_name: QKI, KH domain containing RNA binding Gene_symbol: QKI Gene_synonyms: QK3 Gene_source: HGNC:21100

TATA-Box annotation

---

Distance to TSS:	-104
Nearest PromoterID:	NM_001301085
Entrez ID:	9444
Nearest Unigene:	Hs.510324
Nearest Refseq:	NM_006775
Nearest Ensembl:	ENSG00000112531
Gene Name:	QKI, KH domain containing RNA binding
Gene Alias:	Hqk|QK|QK1|QK3|hqkI
Gene Type:	protein-coding
CpG%:	0.225806
GC%:	0.906250
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@QKI p2@QKI p3@QKI p4@QKI p5@QKI p6@QKI p7@QKI p8@QKI
Sample		p1@QKI	p2@QKI	p3@QKI	p4@QKI	p5@QKI	p6@QKI	p7@QKI	p8@QKI
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.61	4.87	6.04	3.12	2.92	5.45	1.56	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.75	4.25	6.07	4.25	1.82	4.05	1.62	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	15.82	5.40	6.37	1.74	3.28	4.05	1.54	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.02	3.33	5.20	3.74	3.12	4.16	0.83	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.75	4.05	7.65	3.15	3.82	4.05	0.45	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.82	6.59	5.43	2.71	2.52	3.29	1.94	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.89	5.01	5.23	3.27	1.74	6.32	0.44	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.42	3.39	6.06	1.70	2.91	5.57	0.73	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.96	3.42	5.13	2.99	2.56	3.85	0.43	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	4.64	2.90	1.74	2.90	5.22	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.13	3.23	8.49	2.83	4.04	4.85	0.00	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.01	4.47	7.32	2.85	4.88	4.07	1.22	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	23.37	15.31	7.58	6.93	5.48	6.61	1.45	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.79	13.83	8.57	4.81	3.16	5.26	1.35	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.00	12.29	5.71	5.71	3.73	4.39	1.32	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.62	12.07	6.29	8.80	5.78	4.28	3.02	4.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.94	9.83	4.80	5.02	3.49	6.12	1.75	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	12.65	7.17	5.48	3.80	4.64	1.69	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	6.93	10.66	5.86	3.73	2.67	0.53	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.80	13.39	6.77	5.12	3.91	6.02	2.41	4.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.58	13.90	8.15	6.01	5.35	6.55	3.47	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.89	13.81	10.18	5.35	5.18	5.18	3.11	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.90	14.35	6.72	5.82	5.30	6.59	1.42	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.50	14.07	8.49	5.58	5.10	7.04	2.18	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.35	16.00	7.48	7.48	6.97	7.48	2.32	7.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	13.93	5.38	5.70	6.33	8.55	0.95	7.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	9.34	3.30	2.75	4.95	8.79	0.55	7.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.29	20.98	10.61	8.25	7.07	7.31	2.36	10.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.09	13.41	6.78	7.11	4.52	4.85	1.45	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.63	18.28	7.78	6.70	6.15	6.88	3.98	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.47	14.65	7.96	5.44	7.12	6.49	1.67	8.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.54	16.02	6.45	10.55	5.47	5.67	1.76	9.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.47	16.04	8.44	6.12	6.33	6.12	4.22	9.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	19.63	13.20	9.90	5.94	7.75	3.46	1.15	8.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.19	14.77	8.04	7.11	4.86	5.05	2.62	9.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.02	19.35	8.81	8.24	7.47	6.32	3.64	11.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.73	20.03	8.99	11.65	5.31	4.91	2.04	11.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.56	15.92	6.04	9.27	4.84	5.84	1.21	9.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.34	25.93	10.26	10.80	6.75	5.40	2.43	13.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	22.81	18.24	11.76	9.12	6.24	5.76	2.16	12.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.11	15.06	10.12	8.47	7.06	5.88	2.59	11.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.06	16.10	12.15	6.59	6.73	6.73	2.05	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.73	19.61	8.01	9.70	7.38	6.75	3.59	16.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	29.20	18.88	11.19	8.57	8.92	8.39	2.80	14.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.10	21.88	9.84	9.84	8.23	6.02	3.21	14.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.73	21.87	6.05	9.31	8.61	6.75	3.95	12.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.55	24.71	10.32	7.20	9.84	6.24	2.64	15.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.14	19.08	10.73	9.24	6.86	6.56	3.58	16.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.18	22.26	8.86	15.08	8.14	7.66	1.44	19.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	26.49	22.65	10.11	8.09	8.90	4.85	2.22	10.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.75	18.45	6.15	6.15	6.97	6.35	1.64	13.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.46	18.23	5.11	6.23	8.23	5.78	2.67	15.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	69.96	55.97	41.98	55.97	13.99	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.03	10.65	7.45	7.10	6.39	5.32	1.77	7.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.57	14.58	6.30	5.63	3.98	4.97	2.32	10.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	20.97	24.33	7.55	11.75	5.87	3.36	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	17.91	13.32	8.27	7.81	5.05	0.92	8.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	12.32	5.19	6.81	6.16	1.62	1.30	10.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.17	12.53	2.89	4.82	5.46	2.25	2.25	9.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.94	11.63	15.09	5.66	5.66	5.66	1.89	12.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	7.05	3.53	5.64	7.05	2.12	0.71	9.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	6.73	3.93	6.17	5.05	1.68	0.56	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	11.94	29.46	4.78	6.37	8.76	3.18	17.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.19	9.85	8.15	5.10	4.76	6.12	1.70	9.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.17	9.10	2.27	5.20	4.22	2.92	0.32	13.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	7.45	3.19	5.32	2.13	4.97	0.35	11.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	32.33	80.82	0.00	16.16	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	15.79	39.49	7.90	23.69	15.79	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.24	1.95	2.44	4.39	1.46	3.41	0.49	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	3.97	1.98	2.98	0.99	1.49	0.00	7.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	2.81	4.69	3.28	1.88	6.57	0.00	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.90	2.98	6.29	1.99	1.99	4.31	0.66	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.52	1.55	1.86	4.33	0.62	0.93	0.31	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	3.36	2.14	3.97	1.22	2.75	0.00	3.36
Adipocyte - breast, donor1	11376-118A8	19.96	22.17	5.39	5.23	7.29	2.85	0.16	0.63
Adipocyte - breast, donor2	11327-117E4	20.37	28.56	6.26	6.74	14.60	2.73	0.16	0.96
Adipocyte - omental, donor1	11473-119C6	18.70	20.23	6.74	5.98	6.62	4.45	0.38	0.76
Adipocyte - omental, donor2	11474-119C7	14.95	7.47	2.24	9.72	5.98	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	18.42	16.41	3.35	6.03	12.39	1.67	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	10.21	3.19	3.19	3.83	2.55	2.55	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	9.90	3.30	2.20	4.40	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	17.16	9.94	2.26	6.77	5.87	0.90	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	14.77	13.03	3.48	5.21	6.43	1.39	0.35	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	49.28	33.05	8.21	22.30	13.49	5.87	0.20	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	33.97	24.71	5.40	10.55	9.01	3.60	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.94	20.91	5.85	11.15	5.85	5.30	0.28	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	61.13	39.38	12.93	14.11	11.76	4.70	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	51.48	78.74	15.44	24.37	27.75	3.78	1.13	2.25
Adipocyte differentiation, day08, donor2	13023-139D8	39.05	40.02	11.94	17.75	12.26	7.10	0.32	2.58
Adipocyte differentiation, day08, donor3	13026-139E2	23.46	31.46	3.73	11.73	13.33	1.07	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	35.61	40.06	11.69	12.80	9.46	5.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.37	31.61	10.40	13.31	15.39	1.25	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	26.37	31.40	11.80	11.30	9.54	3.01	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	22.91	31.09	12.44	8.84	13.74	2.29	0.33	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	26.79	40.80	13.70	7.92	14.01	2.74	0.00	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	5.08	5.08	4.20	1.33	2.87	0.00	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	1.08	2.15	1.08	0.00	0.72	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	2.40	2.40	2.40	0.00	2.40	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.47	4.68	1.26	4.68	2.34	3.78	0.00	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	6.69	1.67	5.02	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.42	3.29	1.44	1.44	0.62	2.47	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	19.68	14.19	6.41	6.75	4.46	5.95	0.23	1.03
Anulus Pulposus Cell, donor2	11463-119B5	17.88	7.35	3.67	4.65	3.43	1.22	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	4.94	0.90	1.80	1.80	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.99	12.16	3.91	1.74	2.60	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	12.84	4.28	6.42	0.00	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.27	7.47	0.60	3.89	2.69	0.60	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	6.32	2.53	3.79	2.53	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	7.26	1.32	0.00	1.98	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.47	7.15	2.27	1.95	3.90	0.97	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.83	7.77	3.40	3.88	2.91	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	6.53	1.19	1.19	4.75	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.40	10.17	2.26	6.78	3.39	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	7.26	2.90	5.08	1.45	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	6.27	1.25	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.85	10.21	1.81	2.97	3.29	2.14	0.00	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	6.82	2.73	4.09	2.73	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.28	4.67	1.06	1.96	2.41	0.75	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	8.04	1.61	1.07	1.61	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.96	6.42	1.70	2.65	2.08	1.51	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.96	7.22	2.41	1.87	2.41	2.94	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	12.68	3.90	6.83	2.93	1.95	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.96	5.31	1.99	2.16	2.49	1.33	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	2.40	2.40	0.00	3.60	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	3.54	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.58	6.00	1.37	2.57	3.60	1.89	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	3.40	0.00	3.40	3.40	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	4.55	2.28	5.31	3.04	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	3.63	0.00	2.42	3.63	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	5.70	3.99	1.14	1.71	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.48	8.76	1.07	3.42	1.71	2.57	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	3.61	1.03	1.55	1.81	2.06	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.16	5.16	1.88	1.88	3.28	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.25	8.36	1.61	4.82	2.57	2.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	4.28	0.71	1.43	2.85	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	5.26	0.00	1.75	2.92	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.53	9.03	2.11	3.91	2.11	1.51	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	3.56	0.00	1.19	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	6.10	1.53	5.09	3.56	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	7.39	1.53	4.08	2.29	2.29	0.76	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	1.91	0.64	0.00	1.91	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	6.90	0.43	2.16	3.45	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.14	5.50	2.12	2.96	2.54	0.64	1.48	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.96	3.48	1.74	2.90	2.90	0.87	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	11.34	0.94	4.72	1.89	0.94	2.83	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.82	6.61	2.71	3.39	3.39	1.36	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	4.63	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	10.56	0.00	6.34	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.08	5.79	2.36	3.86	3.22	0.86	0.21	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	5.41	1.80	3.01	1.80	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	6.56	4.37	1.46	1.46	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.11	6.90	0.92	4.83	5.06	0.69	0.69	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	2.55	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.08	6.61	0.51	2.80	2.80	0.76	0.00	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.88	7.64	2.06	3.51	4.34	2.06	0.41	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.20	6.43	0.92	2.14	2.75	1.84	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	10.04	1.43	5.26	8.13	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.31	7.10	2.00	3.99	4.21	1.33	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	4.58	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	6.65	1.66	1.66	2.22	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.62	5.56	1.85	2.65	2.12	1.59	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	4.36	1.82	0.73	1.82	0.73	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	28.74	29.60	13.51	15.23	12.53	5.28	0.86	1.47
Astrocyte - cerebellum, donor2	11580-120F5	20.03	11.98	4.62	7.19	4.62	2.23	0.17	0.86
Astrocyte - cerebellum, donor3	11661-122F5	16.36	21.39	6.08	5.45	9.65	2.73	2.10	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	92.03	164.18	71.46	44.97	51.24	10.11	3.83	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	65.68	93.02	42.06	29.93	26.53	13.27	3.40	2.26
Astrocyte - cerebral cortex, donor3	11392-118C6	84.13	88.30	43.70	38.93	27.45	12.23	3.13	4.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.80	3.67	2.64	5.39	0.92	8.03	0.57	1.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	22.93	3.26	3.63	6.64	1.38	5.89	1.25	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.91	3.87	2.39	5.35	1.02	5.35	1.37	1.02
Basophils, donor1	12241-129G9	52.05	30.86	20.92	12.82	8.63	12.82	10.98	6.02
Basophils, donor2	12242-129H1	77.93	42.21	28.14	21.65	16.96	14.43	7.58	3.61
Basophils, donor3	12243-129H2	76.59	46.75	25.14	19.40	14.85	13.23	10.88	7.79
Bronchial Epithelial Cell, donor1	11511-119G8	6.25	1.72	0.65	1.94	0.65	1.08	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	1.37	0.00	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	2.51	2.51	1.26	0.63	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	1.66	1.46	2.91	1.04	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	0.00	1.15	0.46	0.69	0.69	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.24	1.62	1.44	2.70	0.54	3.24	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	18.03	4.23	1.75	4.95	1.96	2.58	0.31	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.56	2.79	1.63	5.36	0.70	4.19	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	27.50	21.74	6.72	6.08	5.12	5.44	7.04	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	10.34	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	137.51	132.44	63.68	31.56	54.66	21.98	34.94	55.79
CD14+ Monocytes, donor2	11305-117B9	139.94	88.53	70.53	27.47	41.20	24.31	55.68	47.14
CD14+ Monocytes, donor3	11381-118B4	116.13	72.89	48.74	27.88	43.25	20.20	46.10	39.08
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	114.07	120.29	57.17	37.36	25.47	13.87	3.40	3.11
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	84.53	74.68	37.91	29.57	20.85	11.37	0.76	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	139.06	135.11	64.10	53.58	31.56	12.49	2.63	5.26
CD14+ monocytes - mock treated, donor1	11863-125A9	87.02	54.78	33.54	23.13	17.35	13.73	8.53	7.08
CD14+ monocytes - mock treated, donor2	11873-125C1	76.94	41.94	31.68	17.50	17.20	11.77	11.16	6.64
CD14+ monocytes - mock treated, donor3	11883-125D2	100.21	49.27	40.98	18.00	16.35	11.61	9.24	9.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	68.80	44.70	28.12	14.23	13.73	10.88	9.71	12.89
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	67.90	36.99	28.98	17.66	14.63	11.04	12.14	15.18
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	79.34	38.68	25.54	17.36	17.36	11.40	12.89	13.39
CD14+ monocytes - treated with BCG, donor1	11860-125A6	54.82	38.18	22.52	13.51	11.94	8.22	11.16	5.68
CD14+ monocytes - treated with BCG, donor2	11870-125B7	57.15	35.79	25.64	14.42	13.89	9.08	11.04	7.48
CD14+ monocytes - treated with BCG, donor3	11880-125C8	80.31	51.58	32.64	17.85	13.93	11.53	9.36	8.71
CD14+ monocytes - treated with Candida, donor1	11868-125B5	84.05	53.62	28.33	19.43	17.33	11.47	20.84	15.45
CD14+ monocytes - treated with Candida, donor2	11878-125C6	111.41	58.08	41.19	23.76	20.07	13.73	30.10	19.54
CD14+ monocytes - treated with Candida, donor3	11888-125D7	96.51	59.91	38.83	16.64	25.52	22.19	27.73	18.86
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	69.32	51.32	31.68	19.19	15.02	11.45	7.59	10.41
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	68.44	41.71	22.55	16.76	13.97	8.58	8.18	5.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	71.62	44.35	21.44	13.74	14.37	10.20	7.50	9.37
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	77.79	55.82	31.34	22.88	17.62	14.18	23.56	20.82
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	100.66	70.58	38.68	19.00	23.53	15.83	19.23	15.61
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	79.00	52.81	33.17	14.84	17.46	10.04	28.81	16.59
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	85.54	51.38	29.05	20.71	16.41	13.72	5.38	4.84
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	79.03	45.88	29.31	18.32	15.00	15.35	6.98	5.23
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	112.78	54.71	31.56	21.46	23.99	13.05	5.05	5.89
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	83.59	57.50	39.87	19.47	17.64	15.98	24.98	28.48
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	105.33	71.16	40.86	18.67	16.91	14.09	32.41	27.83
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	117.14	71.51	37.73	23.69	22.81	20.18	34.22	41.68
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	64.69	35.75	20.58	15.69	15.17	10.11	10.11	6.10
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	57.24	28.25	20.07	9.29	10.41	10.04	9.66	5.20
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	80.40	39.88	29.96	17.68	14.66	13.80	10.99	6.68
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	67.57	54.87	33.17	13.10	21.70	15.15	24.57	27.85
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	93.18	67.45	43.81	22.95	25.50	13.91	29.67	28.74
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	92.33	68.90	41.29	18.79	21.34	16.24	24.13	28.77
CD14+CD16+ Monocytes, donor1	11789-124B7	65.61	35.31	19.62	14.82	14.82	11.33	3.05	3.49
CD14+CD16+ Monocytes, donor2	11801-124D1	54.05	35.34	22.64	11.78	15.01	13.86	4.16	9.24
CD14+CD16+ Monocytes, donor3	11912-125G4	49.17	30.98	25.13	14.73	13.00	11.26	4.12	5.20
CD14+CD16- Monocytes, donor1	11788-124B6	128.31	77.55	44.85	29.28	21.65	18.22	6.38	7.32
CD14+CD16- Monocytes, donor2	11799-124C8	85.05	49.77	32.13	23.05	11.88	13.10	4.72	5.41
CD14+CD16- Monocytes, donor3	11910-125G2	163.66	70.24	50.39	37.46	22.52	19.40	6.91	6.02
CD14-CD16+ Monocytes, donor1	11790-124B8	56.90	45.42	15.57	15.06	25.01	5.36	4.85	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	50.06	34.47	12.73	11.86	12.95	7.47	1.54	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	54.53	30.11	15.79	9.69	16.63	12.42	2.11	2.74
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	4.06	2.03	8.13	4.06	2.03	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.05	4.75	5.42	5.42	0.00	10.85	1.36	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	6.21	5.18	4.14	1.04	7.25	2.07	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	35.71	21.85	11.73	12.79	8.00	12.79	6.40	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	33.24	10.19	5.36	7.50	3.22	12.87	2.14	3.75
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	8.42	4.91	4.91	3.51	3.51	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	30.59	4.71	10.20	3.14	0.78	7.84	2.35	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	3.95	3.95	13.18	0.00	11.86	0.00	6.59
CD19+ B Cells, donor1	11544-120B5	26.30	9.04	13.15	9.86	3.29	20.55	26.30	4.93
CD19+ B Cells, donor2	11624-122B4	31.19	5.08	12.33	8.71	5.80	15.23	18.86	7.98
CD19+ B Cells, donor3	11705-123B4	35.84	14.14	13.13	10.10	3.03	11.61	20.19	8.58
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	38.79	12.53	18.99	9.70	3.64	11.31	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	28.76	9.19	13.58	6.79	5.59	9.19	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	26.11	13.05	8.03	10.04	14.06	4.02	6.02	1.00
CD34+ Progenitors, donor2	11625-122B5	36.52	34.27	28.65	12.36	17.98	5.06	5.62	16.85
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.44	12.02	3.01	10.52	6.39	8.27	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.03	10.37	5.41	9.70	3.16	3.61	1.80	0.45
CD4+ T Cells, donor1	11225-116C1	55.34	28.92	15.71	11.78	9.28	11.07	17.50	5.00
CD4+ T Cells, donor2	11306-117C1	38.58	17.76	12.86	6.12	5.51	7.35	23.88	6.74
CD4+ T Cells, donor3	11382-118B5	47.58	12.20	6.71	8.84	5.79	11.59	11.59	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.20	5.36	6.38	7.15	1.53	8.68	0.77	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.71	6.06	4.04	3.82	1.57	5.61	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.71	4.60	4.31	4.60	1.72	6.04	0.86	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.60	15.17	1.42	7.59	1.42	8.06	3.32	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	39.33	9.83	5.62	9.13	1.40	7.02	3.51	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	9.89	3.30	6.59	3.30	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.62	3.18	1.45	2.60	1.16	4.48	1.01	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.01	2.88	1.69	5.08	0.85	3.90	1.36	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.83	3.71	2.90	2.26	1.29	3.22	1.93	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.86	8.07	3.14	8.52	4.03	5.83	2.24	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.57	10.83	3.84	8.04	1.75	3.14	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.92	3.96	4.84	5.28	2.20	4.84	1.76	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.93	5.06	2.53	3.79	0.00	2.95	0.84	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.21	1.66	0.42	2.91	0.83	2.29	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.70	2.00	1.34	2.34	1.00	2.34	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	37.26	14.14	6.25	5.98	5.17	4.89	2.72	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	40.20	13.93	5.36	7.50	2.68	7.50	3.75	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	1.79	7.17	3.59	5.38	5.38	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.59	5.75	3.34	5.75	1.48	5.93	0.56	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.41	4.98	0.65	3.03	0.87	2.38	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.28	6.30	1.89	4.41	2.52	3.78	1.68	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	35.90	11.63	8.09	6.07	3.03	7.08	4.55	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	24.70	7.37	2.60	5.20	1.73	3.47	6.93	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.20	5.23	3.05	6.54	2.18	6.10	3.92	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	29.20	7.42	2.47	3.46	2.47	6.43	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	21.23	12.00	0.92	8.31	2.77	5.54	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	5.58	1.40	5.58	0.00	1.40	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	45.42	12.74	6.65	9.97	4.98	6.37	2.77	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.66	10.80	4.42	9.57	4.66	3.93	0.98	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	9.24	3.08	6.16	3.08	7.70	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.03	10.74	5.73	9.31	2.51	5.73	0.72	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	9.69	8.31	11.08	0.00	8.31	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	37.65	29.47	10.48	10.48	13.75	12.11	15.39	4.58
CD8+ T Cells, donor2	11307-117C2	35.67	30.79	9.39	8.63	9.39	16.89	28.16	8.63
CD8+ T Cells, donor3	11383-118B6	47.22	27.52	8.84	10.86	12.88	11.61	24.49	5.55
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.95	0.92	1.61	0.92	0.69	2.29	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.15	2.16	1.44	1.44	0.48	2.40	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.83	2.19	0.82	0.82	0.82	3.56	0.27	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.10	1.50	0.90	0.90	1.50	1.20	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.88	1.68	0.48	2.16	0.00	0.96	0.00	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.64	2.73	1.14	2.27	0.68	2.27	0.00	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.65	1.52	1.09	1.74	0.87	0.87	0.22	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.53	3.16	2.11	2.37	0.26	1.84	0.53	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.08	3.05	0.94	4.22	0.94	0.94	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.17	3.62	0.30	3.02	0.00	0.30	0.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.26	2.91	1.74	2.32	0.29	2.61	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.92	2.40	1.33	3.46	0.27	2.40	0.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	8.32	3.94	3.50	1.75	0.44	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.33	7.74	5.92	7.29	2.28	5.01	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	8.20	5.22	3.73	5.97	1.49	0.75	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.48	3.96	2.16	2.52	1.08	2.52	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.77	2.30	1.44	2.01	0.29	2.30	0.29	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.90	3.06	0.94	3.54	0.71	0.94	0.00	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.77	2.54	2.54	3.49	0.63	1.27	0.00	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.99	3.08	0.92	3.38	1.23	1.85	0.31	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.11	1.92	2.56	1.92	0.96	1.92	0.00	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.71	1.53	0.38	1.91	0.00	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	12.22	3.55	0.79	2.36	2.76	0.79	0.00	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	3.78	2.27	3.78	0.76	2.27	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.10	8.83	5.62	9.64	4.82	5.62	0.00	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	9.79	5.60	6.99	6.99	4.90	0.70	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	24.04	11.02	8.01	5.01	7.01	2.00	2.00	3.01
Cardiac Myocyte, donor1	11525-119I4	36.55	20.11	12.79	20.11	12.79	7.31	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	20.26	9.88	2.47	10.38	1.98	1.98	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	24.52	16.94	5.26	10.10	6.73	1.89	0.53	0.84
Chondrocyte - de diff, donor1	11261-116G1	21.49	11.79	2.43	7.97	6.93	1.73	0.00	1.73
Chondrocyte - de diff, donor2	11338-117F6	20.97	15.28	4.26	5.69	6.40	2.49	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	20.37	16.95	3.87	7.96	6.37	2.84	0.46	0.57
Chondrocyte - re diff, donor2	11339-117F7	13.43	12.53	6.27	8.06	6.27	4.48	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	31.54	7.28	2.83	9.71	6.07	6.07	0.81	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	43.72	53.71	27.77	17.10	19.16	11.36	1.72	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	23.09	25.87	17.74	8.76	15.60	8.98	0.86	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	31.24	28.58	16.20	12.74	14.87	11.95	2.21	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	57.86	74.64	31.55	27.60	24.76	13.57	3.67	5.87
Corneal Epithelial Cells, donor1	11526-119I5	7.69	1.10	1.10	1.10	1.10	0.88	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	3.41	2.28	1.14	0.00	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.92	1.79	1.53	1.53	1.02	1.28	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.08	37.15	18.33	12.55	9.41	13.04	0.66	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	66.24	34.06	17.35	11.99	8.83	15.14	0.95	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	6.90	10.35	6.90	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.84	18.25	14.58	12.09	4.86	8.96	0.97	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	79.26	83.02	31.43	23.91	31.77	15.72	5.47	13.67
Dendritic Cells - plasmacytoid, donor2	11309-117C4	58.11	73.77	29.38	25.46	26.11	13.06	5.22	7.18
Dendritic Cells - plasmacytoid, donor3	11385-118B8	103.56	94.37	37.26	33.39	32.42	5.32	3.87	10.65
Endothelial Cells - Aortic, donor0	11207-116A1	20.51	26.85	4.84	7.50	8.34	3.34	0.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	11.15	1.76	3.52	2.35	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	20.08	25.45	4.24	9.90	7.35	2.55	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	18.87	23.59	4.33	6.29	5.90	3.54	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	8.73	12.22	2.91	4.36	5.24	1.75	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	22.59	20.70	3.76	8.94	7.29	1.88	0.00	1.41
Endothelial Cells - Artery, donor3	11413-118E9	18.93	17.36	6.31	6.84	4.38	2.80	0.53	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.29	30.14	9.09	9.75	8.87	7.54	1.33	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.43	31.95	9.43	11.87	9.43	8.22	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	43.98	10.99	16.07	16.91	7.61	1.69	3.10
Endothelial Cells - Microvascular, donor1	11265-116G5	12.18	19.02	6.83	8.02	8.62	0.89	0.59	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	14.06	1.56	5.73	5.21	2.08	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	13.90	21.41	3.26	7.23	5.96	3.12	0.85	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	26.81	34.81	6.40	15.60	16.00	1.60	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	11.53	2.10	4.72	4.19	1.57	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	45.60	73.06	14.66	21.62	17.39	8.95	0.37	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.50	51.71	13.04	18.90	15.86	6.52	0.65	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	49.46	47.26	13.19	23.69	15.63	10.50	0.73	1.95
Endothelial Cells - Vein, donor1	11267-116G7	6.83	11.38	4.55	3.41	2.28	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	20.96	1.40	3.49	4.89	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	21.20	19.63	5.50	9.11	7.22	4.08	0.79	0.47
Eosinophils, donor1	12244-129H3	30.49	15.25	15.25	0.00	15.25	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	310.25	219.48	100.67	75.91	64.36	57.76	74.26	46.21
Eosinophils, donor3	12246-129H5	353.12	235.41	78.47	82.04	78.47	49.94	78.47	71.34
Esophageal Epithelial Cells, donor1	11507-119G4	7.82	1.71	2.44	2.44	0.49	0.73	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.70	13.55	6.16	2.87	3.69	3.69	0.00	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.07	2.63	0.66	1.20	0.99	0.77	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.64	6.07	1.41	4.98	1.08	2.28	0.22	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.98	11.16	4.49	6.31	3.27	2.91	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.33	10.92	3.55	4.64	6.28	3.14	0.14	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.56	8.44	2.53	5.27	4.11	2.32	0.42	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	25.56	9.49	5.80	5.27	5.80	1.32	0.00	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.26	13.29	3.65	7.97	4.65	3.32	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	15.88	11.34	6.35	7.26	11.79	2.72	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	15.92	6.82	3.79	3.79	5.31	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.73	5.99	2.52	3.00	2.52	1.89	0.63	0.95
Fibroblast - Cardiac, donor4	11452-119A3	28.49	34.86	7.27	12.43	7.88	5.15	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	30.08	14.97	6.73	13.07	6.85	4.44	0.76	1.27
Fibroblast - Cardiac, donor6	11460-119B2	26.38	14.40	3.18	9.40	5.46	3.94	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.13	19.16	7.24	10.72	8.58	2.55	0.13	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	28.04	14.67	4.31	12.08	9.49	2.16	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	7.32	7.32	10.25	2.93	13.18	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	35.52	23.76	9.69	12.22	6.00	6.23	0.00	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	27.65	30.87	3.39	13.40	8.65	3.73	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	12.68	11.27	2.58	6.57	4.23	0.70	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.43	5.19	2.36	5.19	6.13	0.94	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	19.22	13.18	4.23	7.13	6.89	2.78	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	31.65	12.55	5.77	12.55	3.96	3.96	0.11	0.79
Fibroblast - Dermal, donor5	11454-119A5	30.53	15.70	6.28	12.21	5.23	5.23	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	30.70	15.11	5.20	13.32	5.20	3.90	0.00	0.81
Fibroblast - Gingival, donor1	11237-116D4	27.07	17.70	5.62	11.24	5.62	3.12	0.21	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.13	14.41	5.24	6.55	7.86	3.14	0.79	1.57
Fibroblast - Gingival, donor2	11318-117D4	23.06	13.57	5.01	10.28	3.03	5.80	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	43.12	22.91	7.54	13.54	5.90	5.51	0.58	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	25.97	1.04	8.31	7.27	1.04	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.85	12.86	3.88	8.99	4.58	2.82	0.70	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	28.84	17.15	4.05	10.45	5.30	2.81	0.00	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.80	11.90	2.57	8.79	3.52	2.70	0.14	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.17	13.76	2.47	7.41	3.18	1.06	0.35	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.84	12.43	2.63	6.58	4.83	2.78	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.41	19.91	4.50	7.64	4.64	3.27	0.27	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.52	15.91	3.29	7.79	5.48	3.07	0.22	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.90	21.86	3.96	10.57	5.58	3.67	0.15	1.03
Fibroblast - Lung, donor1	11270-116H1	8.16	4.08	0.00	2.72	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	29.84	13.43	2.98	2.98	5.97	4.48	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.46	8.23	4.22	4.64	3.38	1.90	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	17.49	4.17	4.17	9.16	2.50	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	6.99	0.00	4.20	9.79	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.08	3.64	0.84	2.80	1.96	0.56	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	36.54	14.61	4.87	9.34	7.31	1.62	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	11.91	0.00	11.91	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.07	12.22	8.92	11.06	2.13	6.98	0.19	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	33.67	13.35	7.74	16.69	5.76	6.22	0.00	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.47	21.42	4.90	14.38	6.43	2.45	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.78	18.32	1.53	11.83	5.72	1.53	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.36	15.66	2.97	8.64	2.97	3.78	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.07	15.66	3.02	8.58	5.10	3.71	0.81	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.81	12.38	2.76	5.64	3.43	2.65	0.33	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.60	16.05	5.49	10.77	7.52	3.45	0.20	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	8.69	1.34	6.68	1.34	4.68	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.02	11.86	1.98	8.70	2.77	1.98	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.14	17.26	12.50	10.12	12.90	1.79	1.59	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.80	16.16	3.91	9.77	7.99	3.91	0.53	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.75	18.33	6.11	10.05	7.10	5.32	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	22.86	14.44	4.81	6.62	6.92	0.90	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.36	16.52	4.97	9.72	4.97	2.48	0.22	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	31.89	14.43	4.81	7.09	4.30	2.02	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	23.14	12.63	4.27	7.55	3.12	4.76	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.29	21.05	4.01	12.03	11.63	2.01	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	26.52	15.57	4.32	9.34	8.84	2.71	0.30	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.47	15.41	9.37	9.97	10.58	3.93	0.30	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.99	21.54	5.96	8.04	7.70	5.05	0.25	1.49
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	28.04	19.32	5.81	7.52	8.72	1.88	0.34	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.68	10.51	4.93	5.58	10.84	1.64	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.03	18.96	4.37	8.73	7.99	2.77	0.11	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	17.54	14.00	3.20	9.45	5.06	3.20	0.34	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.04	8.63	2.67	6.59	3.29	0.94	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	66.48	22.16	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	7.84	6.10	4.36	3.49	4.36	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.79	5.20	1.91	3.99	1.04	1.21	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.08	17.44	3.38	5.20	4.16	2.08	0.00	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.08	7.67	1.28	4.60	2.30	2.56	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	11.48	4.59	3.06	2.30	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.87	10.85	7.66	4.47	3.19	8.93	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	25.67	9.13	8.84	11.41	2.85	19.11	2.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.74	21.23	20.68	15.99	7.45	17.65	1.93	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	40.41	31.74	23.75	15.98	13.70	13.01	5.48	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	22.78	7.73	9.71	7.73	4.56	13.27	1.19	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.67	17.45	16.65	13.22	6.87	12.69	1.59	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	45.01	40.12	18.26	18.26	15.33	10.44	6.85	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	21.67	8.84	7.96	5.75	4.86	12.82	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.33	12.86	12.58	8.20	4.95	9.75	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	32.51	14.90	15.02	12.81	6.03	9.48	0.74	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.71	11.55	9.13	6.72	6.18	11.28	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.56	12.02	15.12	8.55	4.83	7.43	0.74	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.93	9.14	12.60	6.37	3.32	8.86	0.69	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.50	5.49	6.71	3.86	2.24	7.73	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.01	15.29	7.99	9.36	4.79	5.70	1.37	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.27	12.46	9.59	9.72	2.99	7.10	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.92	9.62	6.12	7.87	3.72	10.93	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	20.68	18.32	9.16	7.39	10.64	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.26	21.30	11.76	12.24	7.95	6.99	0.95	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	28.15	14.08	11.84	9.83	6.48	12.06	1.12	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	34.48	23.59	14.72	10.28	7.06	9.48	0.81	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.62	23.07	21.21	12.21	8.99	4.41	1.53	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.71	23.50	10.55	12.15	6.92	12.06	0.71	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.35	33.51	22.06	15.82	11.97	11.24	1.25	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.67	30.74	18.27	14.69	14.86	10.08	1.71	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	42.16	23.57	18.48	12.95	8.96	8.41	2.10	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.54	27.87	16.72	10.82	8.65	9.40	0.92	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.59	20.83	17.56	10.21	7.96	9.39	0.61	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.98	22.69	17.95	9.70	9.70	11.55	2.89	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.70	21.21	20.75	13.14	10.38	8.07	2.42	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.52	17.51	12.51	12.67	7.00	8.00	2.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.66	18.52	18.30	7.05	9.92	9.26	1.10	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	37.51	27.55	20.54	12.30	8.36	7.75	2.46	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.23	24.80	18.32	10.86	8.75	6.81	1.78	2.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.60	22.45	26.62	11.55	12.83	9.62	2.57	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	40.18	19.24	19.61	12.60	8.91	5.97	1.80	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.41	12.34	9.02	8.70	5.54	6.96	0.79	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	32.23	17.03	20.37	10.03	9.73	7.30	4.56	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.29	17.56	17.35	11.81	7.42	5.44	2.40	2.40
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.32	13.39	14.49	9.00	6.81	8.12	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.26	19.08	19.64	8.98	10.10	8.42	3.93	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.66	27.13	8.98	9.81	11.94	4.63	1.57	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.33	11.50	6.42	5.62	6.69	3.74	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.20	18.36	7.80	9.64	8.72	5.05	1.07	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.33	18.39	7.12	9.46	7.12	3.37	1.42	2.20
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.62	14.64	8.67	10.03	10.03	4.07	1.90	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.62	22.86	7.37	7.01	14.38	5.35	1.47	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.66	27.85	11.62	8.55	11.84	4.39	2.63	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	42.65	36.69	14.88	11.90	18.84	4.96	5.95	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.88	25.46	11.08	9.23	12.93	5.28	0.79	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.99	21.18	10.29	8.88	8.07	5.85	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.58	55.15	17.03	14.23	22.62	3.81	0.00	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.45	10.75	18.71	11.15	3.98	8.36	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	31.74	7.40	10.48	7.24	3.08	9.71	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.99	15.55	19.03	13.71	5.73	16.16	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.83	8.14	4.69	4.38	2.19	5.01	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.08	6.78	3.96	5.37	2.26	5.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	30.44	9.22	14.30	7.84	5.53	8.76	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	7.42	2.47	7.42	9.90	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	23.98	12.76	7.35	6.58	9.28	5.03	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	9.63	3.21	12.84	3.21	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	13.91	8.69	5.22	12.17	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.76	15.95	6.84	9.11	7.49	6.84	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.89	14.82	8.24	12.35	8.24	9.06	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	23.33	6.66	10.00	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.29	16.22	12.30	10.07	9.23	8.95	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.21	12.75	10.46	9.15	5.88	5.88	0.33	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	14.26	10.07	10.07	5.87	5.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	20.36	14.31	12.40	12.40	4.13	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.70	16.64	6.79	5.77	8.49	3.74	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	31.32	6.26	6.26	8.35	2.09	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.64	17.18	13.17	16.04	8.02	12.03	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.35	9.77	11.84	8.88	5.03	4.74	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	30.49	10.16	10.16	1.69	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	29.41	28.99	13.25	12.01	8.28	4.97	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.60	25.08	10.59	9.44	12.43	3.68	1.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	21.07	10.54	5.27	10.54	10.54	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.29	14.22	9.61	10.38	8.84	6.15	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.82	16.95	9.78	7.82	5.22	5.54	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	12.04	7.36	9.36	4.68	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	42.38	25.04	22.73	18.11	9.25	14.64	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.29	32.18	17.80	11.98	15.41	12.32	1.71	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	22.36	22.36	19.88	9.94	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.20	13.21	22.65	8.97	3.77	9.44	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.83	14.48	15.69	11.47	10.86	9.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.98	13.23	13.73	9.16	4.58	10.17	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.09	17.95	17.15	11.97	5.18	14.36	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	17.27	18.75	8.88	8.39	11.35	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	10.62	17.71	8.26	8.26	8.26	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	13.42	14.59	7.58	8.75	11.09	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.92	18.87	19.75	11.41	7.90	16.68	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.99	16.95	23.74	11.87	7.63	10.17	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	27.46	28.05	13.13	8.36	13.73	4.18	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	25.23	25.72	9.22	11.65	12.13	4.85	1.94	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	3.42	1.14	6.85	3.42	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.39	12.06	3.74	4.99	5.82	1.25	0.83	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	5.62	3.37	3.37	4.50	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.96	8.25	0.95	8.25	4.76	0.95	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	5.85	1.25	2.51	3.76	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.52	2.44	1.97	2.20	0.46	2.55	0.00	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.78	2.19	3.71	2.19	1.01	2.19	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.15	1.14	2.28	1.82	2.28	1.14	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.32	2.19	1.86	2.40	0.44	1.31	0.00	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	8.60	1.93	4.08	2.58	0.64	1.50	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	1.29	1.51	1.72	0.43	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.22	1.37	2.37	1.00	0.37	1.25	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.89	2.06	2.06	1.89	0.86	1.54	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.45	0.64	1.92	2.24	0.32	0.96	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	27.42	6.16	13.43	14.55	2.24	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.48	9.95	2.16	5.19	3.46	3.03	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	21.15	10.58	10.58	7.93	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.81	15.17	2.12	9.17	3.53	4.23	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	5.09	2.18	4.36	2.91	1.45	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.01	6.99	2.62	6.64	3.32	2.10	0.70	0.35
Hepatocyte, donor1	11523-119I2	35.11	13.32	4.84	7.26	4.84	4.84	0.00	0.00
Hepatocyte, donor2	11603-120I1	31.24	17.24	14.01	8.62	6.46	11.85	0.00	0.00
Hepatocyte, donor3	11684-122I1	38.65	22.09	16.57	7.98	9.20	12.27	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.66	4.57	0.00	7.83	3.92	2.61	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.84	3.15	10.31	2.80	1.40	7.87	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	9.88	6.17	4.80	3.29	4.12	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	3.18	3.18	3.18	3.18	12.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	6.68	0.00	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	2.77	1.38	4.15	0.00	5.54	6.92	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	2.50	0.00	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	11.87	0.00	0.00	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	5.13	2.56	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	4.57	4.57	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	9.75	3.25	3.25	1.62	8.12	4.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	0.00	5.00	8.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	7.26	3.63	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	2.65	7.94	9.26	1.32	1.32	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	1.11	5.54	2.22	2.22	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	5.24	0.00	10.48	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.19	6.30	3.78	5.04	2.52	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	1.55	0.00	3.09	1.55	1.55	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.15	3.23	3.88	3.88	1.94	0.00	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	3.22	0.00	6.44	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	5.70	4.89	3.26	0.00	4.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	2.94	3.36	2.10	0.42	3.36	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	2.41	4.02	0.80	3.21	4.02	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	3.69	3.69	2.77	1.85	3.69	3.69	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.75	3.78	2.36	3.78	1.89	2.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	5.44	3.63	2.72	2.72	2.72	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	4.30	5.38	2.15	2.15	1.08	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	1.27	2.54	1.27	5.08	5.08	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	2.55	3.83	1.91	1.91	0.64	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	1.82	5.47	0.00	7.29	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	3.57	2.14	3.57	2.14	1.43	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.20	1.54	4.32	2.78	0.62	2.16	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	1.76	5.27	3.51	0.00	1.76	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.86	5.56	5.56	9.74	0.00	2.09	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	4.43	15.49	2.21	6.64	6.64	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	9.73	0.00	6.48	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	3.49	7.85	4.36	1.74	3.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	0.00	6.75	6.75	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	0.00	6.97	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	1.07	2.13	1.07	1.07	3.20	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	2.77	6.93	5.54	2.77	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	5.70	5.70	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	6.44	2.76	3.68	0.00	4.60	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	3.03	6.05	3.03	0.00	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	18.63	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	1.06	2.11	2.11	1.06	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.00	4.73	2.28	2.61	1.39	1.14	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	7.61	1.76	0.59	2.34	1.17	2.34	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	19.03	4.83	2.93	4.35	2.08	3.12	0.19	0.28
Keratinocyte - oral, donor1	11251-116E9	20.77	3.29	3.75	5.45	1.70	4.43	0.11	0.57
Keratocytes, donor1	11527-119I6	37.48	14.44	11.00	11.69	5.50	8.25	0.00	1.72
Keratocytes, donor2	11607-120I5	11.72	3.52	3.52	4.69	1.17	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	23.32	9.09	7.11	6.13	2.96	8.50	0.79	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	6.59	13.19	2.20	10.99	13.19	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	3.24	8.63	5.39	5.39	3.24	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	32.41	43.48	26.87	17.76	18.45	11.19	1.61	1.85
Lens Epithelial Cells, donor3	11690-122I7	28.15	24.52	11.40	12.61	10.60	7.87	0.50	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.94	22.17	6.52	7.71	5.69	3.32	0.95	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	11.44	5.58	3.63	1.95	3.07	1.12	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.10	27.23	8.97	8.50	8.66	3.78	2.36	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.37	15.59	4.30	7.53	6.99	1.61	0.54	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.40	14.18	4.10	4.73	2.21	1.89	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.52	13.05	3.23	4.31	3.45	1.73	1.08	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.52	18.06	5.34	7.39	8.21	6.98	1.64	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	8.34	2.53	2.53	1.52	1.77	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.25	15.62	4.93	5.49	3.38	2.96	0.84	2.11
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.96	21.75	8.31	5.93	5.54	1.19	1.19	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.41	16.87	5.04	7.37	5.62	4.07	1.55	3.10
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	7.78	1.48	2.96	2.04	1.85	0.37	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.59	21.25	10.80	9.06	5.92	2.79	0.00	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.93	14.79	3.82	5.96	5.01	1.19	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.06	11.40	3.43	3.71	3.85	1.92	0.41	2.06
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	19.71	8.93	8.93	6.78	3.08	1.54	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	8.11	2.18	2.18	2.18	1.56	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	15.01	3.66	3.29	4.21	2.20	0.55	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.09	19.42	8.89	6.58	7.57	4.28	0.66	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	9.08	2.05	2.93	2.05	0.88	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.21	12.70	3.98	3.49	3.24	0.50	0.75	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	20.85	5.82	6.79	4.85	3.39	1.94	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.73	13.20	6.19	5.66	4.85	2.42	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.66	16.80	5.90	4.09	3.63	1.82	1.06	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	16.07	7.78	5.18	7.78	2.07	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	17.38	20.94	7.75	8.38	7.33	2.72	2.30	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.17	14.89	3.91	4.81	4.96	1.65	1.05	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	19.95	6.88	6.88	4.13	2.06	0.00	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	16.18	3.39	5.64	3.95	1.13	0.56	1.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.00	10.82	2.86	2.86	1.80	1.70	1.70	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	15.02	9.21	7.27	6.78	2.91	0.97	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.90	14.55	3.31	3.64	4.96	3.64	0.33	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.31	13.01	3.84	3.59	3.72	1.12	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.25	25.91	7.77	5.55	8.51	4.44	1.11	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.59	14.82	5.93	4.69	2.72	4.20	0.99	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	10.59	3.30	3.16	2.89	2.75	0.55	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	23.48	9.01	8.68	8.04	4.18	0.96	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.91	28.61	6.39	7.30	7.91	4.87	0.61	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.84	19.74	4.90	7.42	6.44	3.36	0.84	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	18.49	8.18	7.82	6.04	5.69	1.42	3.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.18	10.18	3.88	1.94	1.45	1.94	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.00	7.16	1.40	2.96	1.56	1.40	1.09	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.25	14.32	3.94	4.30	6.45	2.86	0.00	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	12.09	5.88	5.88	5.23	3.59	0.33	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	5.41	1.41	0.94	1.18	0.94	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	24.38	6.44	8.54	6.44	5.20	1.24	1.98
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	9.99	5.12	2.05	2.56	1.28	0.51	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	11.64	3.88	3.58	2.69	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	6.80	2.27	0.00	2.27	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	4.60	1.53	0.77	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.23	4.45	2.97	0.74	1.48	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.65	3.39	2.96	1.27	3.39	1.69	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	2.11	1.41	0.00	0.70	1.41	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.93	1.87	1.87	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.09	2.06	0.52	1.03	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	4.76	2.38	1.19	3.57	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	4.52	4.98	0.90	2.04	1.13	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	7.27	3.49	2.04	2.33	2.33	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.10	2.70	1.80	1.35	2.25	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.13	5.69	2.03	2.30	2.44	1.08	0.00	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	5.65	2.05	1.54	2.57	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	11.29	3.53	1.41	3.88	2.47	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	4.00	2.67	0.67	2.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	4.58	1.02	1.53	2.55	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.41	6.14	2.13	1.33	3.20	0.53	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	9.83	5.67	3.59	2.27	2.46	1.70	0.19	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5.52	2.45	1.23	0.00	0.61	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	2.45	0.00	0.00	2.45	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.41	4.37	3.33	2.50	4.16	1.25	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.61	3.36	1.96	1.68	3.36	0.56	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	4.12	1.03	4.12	1.03	1.03	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.55	5.23	2.61	4.35	4.06	2.03	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.88	4.78	1.49	1.20	2.69	1.20	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	2.77	2.77	2.77	2.77	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.01	5.66	4.95	1.77	4.24	2.83	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	9.59	1.48	1.84	1.84	1.84	1.84	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	3.45	1.15	2.30	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.21	3.84	1.15	2.30	0.77	0.38	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5.66	2.26	3.96	0.57	2.26	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	1.64	1.64	0.82	0.82	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	5.87	0.90	1.81	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	2.15	5.03	2.15	2.15	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	2.24	2.99	4.48	1.49	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.32	3.34	3.34	2.60	2.23	1.86	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.31	5.60	2.15	1.72	1.72	1.29	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	3.43	0.86	2.57	2.57	2.57	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.00	2.00	2.33	0.67	1.33	1.00	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	3.62	2.41	1.81	0.60	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	5.69	0.71	1.42	0.71	1.42	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.53	3.09	2.41	2.06	1.37	0.69	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	4.29	1.61	1.07	1.61	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	3.37	3.37	1.35	2.02	0.67	0.00	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	6.30	5.93	3.33	2.59	0.74	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	2.33	1.16	4.65	3.49	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	0.00	0.00	0.00	0.00	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	4.40	4.00	2.00	0.40	2.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	3.63	1.45	0.00	1.45	1.45	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	3.83	0.77	3.07	0.00	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	3.95	1.48	0.99	1.48	1.97	2.96	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	1.88	2.82	0.94	1.88	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	2.51	0.00	2.51	2.01	0.50	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.11	1.80	4.51	1.35	2.25	0.90	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	1.72	1.72	1.72	3.44	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	3.56	1.78	0.45	4.01	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	6.65	2.35	1.96	1.17	0.39	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	1.32	1.32	1.98	2.64	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	4.67	4.67	2.08	4.67	3.11	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.56	4.81	2.63	1.75	2.63	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	3.35	2.80	0.56	0.00	2.24	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	3.53	2.21	3.53	1.77	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	4.63	1.93	3.09	1.93	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	4.05	1.01	2.03	2.03	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.69	4.81	0.48	1.92	1.44	0.96	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3.98	2.39	2.78	1.99	0.40	2.78	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	1.22	0.00	0.61	3.04	1.22	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	4.15	0.69	0.69	0.00	0.69	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	5.70	3.04	3.80	1.90	1.52	0.38	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	6.20	4.13	1.03	1.03	2.58	2.58	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	3.63	0.60	1.21	3.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	6.02	5.07	4.44	1.58	3.17	1.90	0.32	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.53	0.53	0.53	1.07	2.67	2.13	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.75	1.72	1.72	1.15	1.72	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.69	5.14	3.09	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	2.83	0.00	0.00	2.12	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.92	2.27	2.27	0.57	1.70	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	2.50	4.58	2.08	2.08	0.83	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	5.48	0.00	1.57	1.57	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	4.59	1.67	0.42	1.25	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.90	2.32	3.25	0.00	1.86	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	3.35	0.67	0.67	2.01	0.00	2.01	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.88	2.67	0.53	1.60	0.53	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.06	4.85	1.62	2.02	1.62	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	4.59	1.84	2.75	0.92	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	1.78	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	4.56	0.57	1.71	0.57	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	1.53	1.53	0.77	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.66	1.09	1.64	2.19	2.74	0.55	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.91	1.34	2.23	0.89	2.67	0.89	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	5.72	3.38	1.30	1.04	2.34	1.30	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	4.64	3.32	3.32	1.99	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	4.16	2.08	2.08	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	74.98	59.26	40.11	26.67	12.54	9.34	0.91	2.96
Macrophage - monocyte derived, donor2	11313-117C8	39.45	14.31	8.62	10.64	4.59	8.07	0.18	0.92
Macrophage - monocyte derived, donor3	11389-118C3	62.53	35.65	19.53	18.22	13.24	10.75	1.44	2.49
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	11.15	2.66	3.19	2.12	3.72	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	14.10	7.76	5.07	5.55	3.96	2.06	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	13.34	7.51	5.56	4.17	3.47	1.67	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	24.91	10.26	3.79	4.58	3.69	2.69	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	13.90	5.50	2.61	3.47	2.90	2.32	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	5.49	2.24	0.75	1.50	1.50	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	19.66	50.17	1.36	13.56	13.56	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	50.83	40.99	14.38	17.95	16.22	7.14	1.73	1.95
Mast cell, donor2	11565-120D8	87.67	28.53	11.59	20.51	10.10	19.32	13.97	7.13
Mast cell, donor3	11566-120D9	104.01	36.02	14.41	26.79	13.06	21.39	14.41	5.63
Mast cell, donor4	11567-120E1	82.44	35.64	12.06	25.00	10.28	14.71	16.49	8.69
Mast cell, expanded and stimulated, donor5	11940-126A5	39.37	18.19	4.55	7.98	4.32	5.10	0.11	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	35.60	6.42	11.09	7.59	6.42	0.00	2.92
Mast cell, expanded, donor5	11939-126A4	38.32	16.86	4.82	9.41	5.39	5.85	0.46	1.38
Mast cell, expanded, donor8	11941-126A6	59.08	53.22	13.22	15.06	13.89	9.71	1.34	1.84
Melanocyte - dark, donor1	11502-119F8	18.71	28.66	10.55	11.34	8.76	7.26	0.90	1.09
Melanocyte - dark, donor2	11582-120F7	16.61	13.15	3.11	10.73	4.15	2.42	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	23.83	13.98	6.66	8.98	4.78	6.09	0.14	0.14
Melanocyte - light, donor1	11274-116H5	12.69	6.35	4.70	3.06	1.65	1.65	0.24	0.94
Melanocyte - light, donor2	11351-117H1	15.70	4.78	2.05	2.05	3.41	2.73	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	3.47	4.34	1.73	4.34	2.60	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	26.66	10.10	4.79	9.48	2.39	3.44	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	8.07	4.84	3.23	3.50	0.81	3.23	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	19.29	14.46	13.39	8.04	4.82	6.96	0.27	1.87
Meningeal Cells, donor1	11493-119E8	30.52	17.24	11.04	13.27	6.08	4.22	0.37	0.87
Meningeal Cells, donor2	11573-120E7	24.21	13.64	6.60	7.92	6.16	3.08	0.00	1.76
Meningeal Cells, donor3	11654-122E7	23.39	21.92	8.88	9.37	5.38	7.82	0.41	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.25	9.12	3.42	4.85	2.28	1.71	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.67	11.37	3.42	3.12	5.03	4.13	0.40	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	6.57	1.31	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	0.00	0.00	1.31	0.00	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	8.61	2.87	5.74	3.59	2.87	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.25	11.65	3.60	7.20	6.56	4.24	0.64	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	10.05	4.02	4.52	2.01	2.51	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.19	6.81	1.98	3.96	2.64	2.86	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	2.92	2.92	2.19	2.19	2.19	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.39	2.66	2.25	1.43	1.64	1.64	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.24	5.40	2.35	6.65	4.16	1.52	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.78	5.58	0.74	2.97	2.97	1.86	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.55	15.00	4.21	9.08	4.34	6.32	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	9.79	3.26	4.75	4.15	1.19	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	7.01	0.00	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	8.97	1.28	1.28	1.92	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.55	13.11	3.54	9.92	1.06	2.84	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.70	8.13	4.38	9.69	3.75	3.13	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	6.53	3.63	7.98	3.63	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	12.46	14.32	3.45	6.63	4.24	2.39	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	8.01	4.00	3.00	2.00	3.00	1.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	14.45	8.31	2.17	5.49	4.26	3.54	0.36	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	79.67	89.12	21.61	27.01	24.31	13.50	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.30	43.34	20.93	16.75	12.31	4.68	0.99	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.34	30.33	12.37	13.25	10.31	9.72	0.59	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	72.60	62.23	31.11	13.83	13.83	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	37.19	31.61	16.43	15.81	8.99	4.65	1.55	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.87	21.78	11.20	9.96	9.33	6.22	0.41	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	50.95	27.79	16.21	16.21	16.21	4.63	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	43.80	28.78	19.27	14.26	11.26	6.26	1.25	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	50.27	46.08	12.10	13.96	9.78	10.24	0.47	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	58.40	19.47	19.47	19.47	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.03	31.30	16.87	13.21	7.93	5.49	1.22	3.25
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.47	28.11	14.65	12.27	10.69	4.75	0.40	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	68.41	17.10	8.55	8.55	25.65	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	19.47	13.27	12.39	6.19	7.96	1.77	4.42
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.48	21.66	9.50	7.98	7.22	6.84	0.76	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	90.80	34.21	27.63	17.11	5.26	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	28.44	28.23	12.52	10.82	10.61	3.61	0.64	2.97
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	29.47	26.70	12.89	19.34	10.13	5.52	0.92	7.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	45.30	33.98	16.99	15.80	11.92	4.17	2.38	7.15
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	46.95	41.92	13.41	16.77	13.41	11.74	0.00	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	67.90	0.00	0.00	67.90	101.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.37	27.10	12.04	10.54	12.04	4.77	2.76	5.52
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.62	26.38	9.74	8.32	6.18	7.84	0.24	3.33
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.21	45.34	24.88	11.61	17.14	12.16	2.21	6.08
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.10	23.95	14.97	8.52	11.97	6.68	3.22	5.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	28.19	21.03	10.31	6.31	9.04	4.63	1.47	4.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.68	27.31	8.76	6.32	9.99	6.52	3.87	4.48
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.10	25.53	13.09	10.51	9.87	5.36	3.65	4.08
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.79	25.56	9.34	8.00	8.22	7.11	2.00	4.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	61.91	10.32	10.32	30.96	10.32	0.00	30.96
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.28	26.72	13.58	10.29	9.42	4.38	1.10	5.91
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	30.42	28.90	10.65	8.62	8.11	6.59	0.51	4.56
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	44.74	24.85	11.60	11.60	4.97	14.91	1.66	6.63
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.97	29.35	11.69	14.13	13.86	8.97	3.81	9.51
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.70	17.94	13.23	7.65	7.94	6.18	0.59	6.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	27.26	17.45	4.36	10.90	5.45	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	11.05	7.69	6.73	3.36	3.36	1.92	8.17
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.81	21.61	7.20	8.00	5.20	6.80	0.80	4.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	19.20	8.23	8.23	9.60	5.48	1.37	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.52	14.02	6.51	8.51	6.01	4.00	1.50	5.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	20.39	6.12	14.27	2.04	20.39	2.04	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.71	8.76	5.26	2.63	6.57	2.19	1.31	6.13
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	23.18	12.14	15.45	11.04	14.35	0.00	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	24.33	15.37	11.53	9.61	11.53	3.20	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.59	8.93	6.69	5.21	5.95	6.45	0.74	3.22
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	26.44	15.31	11.13	6.96	6.96	0.00	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	22.10	17.68	2.21	17.68	22.10	0.00	11.05
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.15	12.65	6.15	6.50	2.39	4.79	0.68	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.07	24.51	12.69	15.32	10.07	7.00	3.50	5.69
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	42.26	20.60	16.33	8.88	7.81	7.81	1.78	7.10
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.96	9.26	5.05	5.33	3.37	3.65	0.28	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	34.50	15.79	12.88	9.14	6.65	7.07	0.42	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	32.05	23.31	9.91	5.24	5.83	9.32	1.17	3.50
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.15	11.46	8.14	5.43	5.13	4.22	0.30	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.97	14.61	7.93	5.43	5.84	2.92	0.42	3.76
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	21.66	14.44	21.66	0.00	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	12.93	4.62	5.54	8.31	3.69	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.87	15.94	13.66	11.38	6.26	6.26	0.57	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	41.32	17.13	11.88	10.36	4.42	4.28	0.69	3.73
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.10	10.37	7.26	6.74	3.11	4.15	0.52	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	34.32	11.58	16.30	3.86	6.01	4.72	1.29	4.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	29.22	17.79	17.15	10.16	2.54	8.89	1.27	3.18
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	28.29	12.54	9.07	7.74	4.80	6.94	0.53	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	44.30	29.03	19.76	9.28	8.08	5.09	1.20	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	31.64	13.70	12.43	8.05	3.25	3.81	0.85	2.83
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.24	10.19	6.37	5.41	4.78	3.82	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.96	16.58	17.69	8.85	3.54	4.64	0.88	3.54
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.47	21.24	12.51	9.86	6.45	7.58	1.14	3.03
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.04	12.78	8.24	7.39	4.55	1.99	0.85	5.11
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.04	10.32	13.52	7.37	5.65	3.20	0.74	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	37.80	24.76	20.20	12.38	4.56	11.73	2.61	8.47
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.35	13.23	13.82	7.94	3.23	6.17	0.88	3.53
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	34.60	17.30	13.55	8.36	8.07	7.50	1.44	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	70.06	49.05	18.96	12.36	11.54	16.07	1.65	5.77
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	34.84	19.06	12.51	8.93	6.55	8.34	0.60	3.28
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	7.53	7.53	7.53	18.83	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	24.95	8.91	5.35	7.13	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.64	39.43	21.36	20.70	10.19	3.94	1.31	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	18.94	10.52	9.47	10.52	3.16	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	36.37	34.79	14.83	15.81	8.11	5.14	0.79	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	16.76	14.90	13.97	4.66	6.52	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	30.42	36.05	9.01	13.89	10.51	4.51	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.17	13.85	6.39	4.79	4.26	3.46	0.27	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	54.63	38.68	22.73	18.66	8.37	7.46	0.68	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	23.58	10.31	7.37	8.84	2.21	1.47	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	41.77	30.41	20.15	17.95	8.43	4.40	0.73	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	32.67	18.67	18.67	6.22	6.22	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	31.53	31.53	12.83	12.29	6.41	2.67	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	7.73	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	28.28	12.12	14.14	6.06	4.04	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	18.97	7.59	9.70	5.90	3.37	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	40.86	34.05	14.98	5.45	16.34	5.45	4.09	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.07	21.62	2.54	4.45	20.35	1.27	1.27	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	15.39	27.53	4.86	6.48	10.53	3.24	0.81	4.86
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	12.08	6.04	9.06	6.04	10.57	3.02	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	222.70	279.80	85.65	79.94	142.75	17.13	39.97	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	58.72	16.31	13.05	45.67	9.79	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	57.03	19.01	4.75	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	25.10	62.75	12.55	37.65	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.02	14.43	6.03	10.13	8.62	6.68	0.43	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.34	13.07	8.88	4.70	10.97	6.79	2.09	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	7.34	1.33	4.00	3.34	2.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.35	5.01	1.67	2.09	2.09	1.25	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.50	8.37	5.89	6.27	2.66	6.65	1.14	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	25.53	9.58	9.58	15.96	9.58	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	4.76	0.68	3.40	2.72	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	9.19	9.19	5.51	7.35	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	3.35	0.84	3.35	2.09	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.74	3.25	1.63	2.09	3.02	1.63	0.23	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.73	9.19	0.81	3.78	2.70	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.81	18.08	4.84	7.57	6.10	2.73	0.42	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	11.13	11.13	11.13	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	4.96	0.50	1.49	1.99	0.50	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	8.12	1.89	3.52	1.89	3.25	1.08	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.21	5.21	0.23	2.27	3.17	0.68	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.06	8.65	0.98	2.78	4.25	1.63	0.49	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.79	21.69	6.93	11.85	8.20	3.65	0.36	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.55	8.49	1.06	3.71	4.77	1.06	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	5.40	3.00	3.00	0.60	1.80	0.60	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.17	13.78	7.22	4.27	2.63	3.28	1.31	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	6.02	0.65	2.76	2.28	0.65	0.81	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	38.27	31.04	8.82	13.41	13.58	3.00	0.71	3.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	9.14	1.41	2.81	4.92	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	8.73	0.92	5.98	3.22	0.92	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.03	9.64	1.29	3.86	5.46	1.29	0.00	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.28	11.04	8.28	3.79	5.86	2.41	1.03	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	73.32	37.93	30.34	17.70	22.76	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	37.65	32.97	7.80	12.70	16.49	3.79	0.89	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.16	12.70	3.81	5.08	2.96	3.39	0.42	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.26	8.31	3.32	3.80	3.32	1.90	0.24	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	11.16	9.87	0.43	5.58	3.00	0.00	0.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	54.17	72.22	54.17	36.11	9.03	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.66	11.00	2.33	7.00	7.66	1.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.84	28.86	7.21	11.72	10.82	3.16	0.00	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.30	11.51	1.19	4.36	4.36	1.19	1.19	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	3.71	0.00	4.64	3.71	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.38	10.59	4.16	5.30	3.03	4.54	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.36	8.80	2.28	6.84	4.56	1.63	0.33	3.26
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	10.89	3.92	7.41	7.84	3.05	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.92	33.92	13.12	13.12	21.26	3.62	1.36	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	6.17	0.00	3.53	7.06	0.88	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	9.31	0.66	3.32	3.32	1.33	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	9.92	0.99	6.94	4.46	0.00	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	10.34	1.15	3.45	4.21	1.15	0.38	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	6.65	10.59	3.93	1.81	5.14	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.87	24.31	8.62	8.40	12.60	3.76	0.44	1.77
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	4.74	0.68	3.39	5.42	2.03	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	40.88	15.33	5.11	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	10.97	1.22	4.88	6.10	1.22	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.02	11.65	2.52	5.04	5.35	3.46	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.20	9.08	1.51	7.26	2.42	2.42	2.12	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	13.45	2.37	7.12	1.58	1.58	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	17.00	11.34	4.53	10.20	4.53	3.40	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	50.58	30.35	10.12	20.23	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	12.80	14.41	4.47	4.22	5.96	2.48	0.00	0.99
Myoblast, donor2	11322-117D8	24.55	17.64	5.18	9.01	5.56	3.45	0.19	1.34
Myoblast, donor3	11398-118D3	25.39	29.43	9.59	15.64	11.44	3.36	0.00	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	21.89	4.38	3.50	5.40	3.79	5.11	0.15	0.29
Natural Killer Cells, donor1	11230-116C6	44.59	32.90	21.53	8.61	12.30	16.61	14.15	6.77
Natural Killer Cells, donor2	11311-117C6	34.68	26.54	12.97	10.55	14.17	17.19	37.39	5.73
Natural Killer Cells, donor3	11387-118C1	41.78	24.85	16.93	13.62	14.91	19.14	35.15	5.89
Neural stem cells, donor1	11275-116H6	168.40	355.32	36.66	66.42	124.85	12.70	4.72	6.17
Neural stem cells, donor2	11352-117H2	98.21	165.61	38.51	34.66	71.25	11.55	3.85	5.78
Neurons, donor1	11494-119E9	44.38	53.48	25.03	25.03	19.34	4.55	2.28	2.28
Neurons, donor2	11574-120E8	36.77	72.87	30.38	16.51	19.15	6.38	3.74	3.30
Neurons, donor3	11655-122E8	36.18	29.60	15.62	9.87	16.44	4.11	4.93	2.47
Neutrophils, donor1	11233-116C9	152.19	77.02	38.05	25.98	32.48	38.98	9.28	13.92
Neutrophils, donor2	11314-117C9	194.22	101.46	43.48	34.79	37.69	72.47	20.29	2.90
Neutrophils, donor3	11390-118C4	273.66	97.73	58.03	48.87	32.99	66.58	28.71	20.16
Nucleus Pulposus Cell, donor1	11252-116F1	31.11	21.61	5.22	11.16	5.70	6.41	0.24	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	3.91	0.65	2.60	0.98	2.60	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	16.45	9.02	3.81	5.01	4.21	3.01	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	15.97	15.55	3.30	7.57	7.57	2.34	0.69	1.10
Olfactory epithelial cells, donor2	11934-125I8	14.62	14.19	2.32	5.36	3.91	3.91	0.43	1.01
Olfactory epithelial cells, donor3	11935-125I9	12.26	8.29	1.93	3.52	3.52	3.29	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	26.39	14.22	3.70	7.01	5.55	5.26	0.29	1.66
Oligodendrocyte - precursors, donor1	11496-119F2	21.67	9.63	12.04	9.63	3.01	4.21	0.60	2.41
Osteoblast - differentiated, donor1	11276-116H7	12.34	8.72	3.19	5.32	4.04	1.28	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	5.72	5.72	0.00	1.14	3.43	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	4.34	4.34	6.21	2.48	1.24	0.00	0.62
Osteoblast, donor1	11277-116H8	10.16	8.40	2.35	3.13	1.37	1.17	0.20	0.78
Osteoblast, donor2	11354-117H4	28.09	17.56	7.73	8.43	3.51	4.21	0.00	0.00
Osteoblast, donor3	11426-118G4	17.77	12.09	3.02	9.42	5.69	4.27	0.36	0.53
Pancreatic stromal cells, donor1	11249-116E7	23.00	15.58	4.30	6.91	3.87	3.29	0.08	0.42
Pericytes, donor1	11491-119E6	8.79	8.57	2.89	3.78	3.23	1.34	0.22	0.33
Pericytes, donor2	11571-120E5	15.39	11.54	6.56	6.34	6.79	3.40	0.45	1.36
Pericytes, donor3	11652-122E5	12.82	9.77	3.05	4.68	4.48	2.85	0.00	0.41
Perineurial Cells, donor1	11499-119F5	22.27	11.87	8.25	9.49	4.18	5.31	0.34	0.79
Perineurial Cells, donor2	11579-120F4	23.74	19.78	5.43	12.24	4.69	2.94	0.46	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	100.72	53.55	30.28	20.40	15.30	18.17	3.82	9.56
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	71.99	38.44	21.79	15.43	12.98	16.90	25.71	11.51
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	61.60	32.74	20.84	13.98	12.17	14.88	13.59	13.07
Placental Epithelial Cells, donor1	11278-116H9	4.78	3.35	1.91	1.91	3.35	0.96	0.24	0.96
Placental Epithelial Cells, donor2	11355-117H5	2.22	6.65	2.22	1.11	2.22	1.11	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	7.46	3.53	1.37	1.96	1.77	1.77	0.20	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.59	6.33	3.80	3.16	2.22	2.53	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	16.13	17.82	2.44	4.69	5.82	4.13	0.00	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.97	15.40	4.31	7.96	4.18	2.48	0.13	0.78
Preadipocyte - breast, donor2	11328-117E5	21.39	15.31	4.28	7.66	6.75	2.48	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	14.28	11.83	3.73	5.01	5.43	5.01	0.11	0.85
Preadipocyte - omental, donor2	11329-117E6	19.64	13.53	4.36	3.93	6.55	4.36	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	17.19	11.46	3.58	5.16	5.16	5.59	0.72	1.00
Preadipocyte - perirenal, donor1	11469-119C2	13.78	8.86	0.98	4.92	2.95	0.98	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	10.75	9.21	1.84	3.99	3.99	1.54	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	36.12	19.66	2.30	10.98	6.55	2.12	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	24.52	14.13	1.36	9.54	6.13	1.70	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	35.21	22.26	3.54	8.57	6.43	2.42	0.28	0.75
Preadipocyte - visceral, donor2	11357-117H7	27.15	15.19	2.76	8.74	0.92	4.60	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	19.12	9.93	1.88	7.11	6.16	2.09	0.00	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.22	6.03	9.20	2.87	1.81	9.20	0.00	1.06
Prostate Epithelial Cells, donor2	11331-117E8	7.45	3.11	1.62	2.03	1.35	2.30	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.12	1.59	3.86	1.71	0.92	3.92	0.18	0.43
Prostate Stromal Cells, donor1	11254-116F3	12.42	9.45	2.73	4.78	2.16	2.16	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	19.54	12.91	5.92	6.28	6.45	4.12	0.00	1.26
Prostate Stromal Cells, donor3	11405-118E1	16.89	10.84	2.29	6.67	3.86	3.02	0.31	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	7.30	4.74	2.19	2.55	4.01	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.74	11.58	7.49	5.89	2.77	6.65	0.49	1.04
Renal Epithelial Cells, donor1	11517-119H5	10.65	4.06	1.52	5.58	1.01	2.54	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	4.27	2.13	4.27	1.42	4.27	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	16.51	10.27	8.36	5.50	3.49	8.05	0.42	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	11.57	4.77	6.13	7.49	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.21	13.07	4.72	6.20	5.53	1.48	0.27	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.86	27.97	9.55	13.99	9.77	5.33	0.44	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.98	9.32	2.00	3.33	1.33	2.66	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	10.56	5.28	3.30	5.06	1.76	3.30	0.22	0.88
Renal Mesangial Cells, donor2	11598-120H5	11.29	6.27	3.13	5.02	4.39	1.88	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	4.72	3.33	0.55	1.66	1.39	1.66	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.72	7.25	4.83	6.44	3.22	4.83	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.23	4.64	2.95	3.80	0.42	0.00	0.42	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.04	8.49	4.82	7.71	3.66	3.28	0.19	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.93	6.48	4.93	3.89	1.30	6.22	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	5.97	1.71	3.41	3.41	3.70	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	3.09	1.03	2.06	1.03	3.09	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.05	6.27	6.52	1.25	3.01	10.54	0.00	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	65.08	50.78	18.71	22.72	10.42	17.37	2.00	2.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.03	10.72	16.08	6.25	10.72	10.72	1.79	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	26.42	8.26	14.31	4.40	4.95	7.15	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	71.93	22.04	30.74	9.86	4.06	12.76	0.00	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	64.88	25.35	17.16	14.95	9.88	6.76	1.04	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	47.07	22.15	11.02	10.92	6.95	11.02	0.99	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	52.42	27.55	13.83	12.72	7.47	10.93	0.78	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	62.15	21.71	20.47	14.64	8.81	7.81	1.36	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.10	21.09	12.59	12.00	5.13	9.44	0.93	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	57.55	24.50	14.79	12.71	8.32	13.64	0.46	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	50.38	20.13	14.79	10.27	7.39	5.61	2.05	3.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	45.99	21.93	12.56	12.56	7.71	8.02	0.61	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.44	32.61	17.74	15.23	8.24	12.72	0.90	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	40.17	16.50	13.34	9.32	7.46	4.73	1.29	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	43.35	18.78	12.66	9.55	6.33	10.19	1.07	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	46.47	19.91	11.06	12.17	5.31	8.63	0.89	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	45.88	14.15	15.68	12.62	9.94	4.21	2.68	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.18	24.60	13.69	12.48	7.17	10.53	1.68	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	56.94	33.26	15.03	10.15	9.02	14.28	0.38	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.44	22.29	18.98	14.33	10.35	5.97	1.86	5.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	57.72	26.18	12.17	13.43	9.83	11.00	1.36	3.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.03	25.97	14.70	11.46	7.64	7.45	0.95	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	54.57	20.08	17.62	12.82	8.22	4.59	1.07	3.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	48.49	26.91	10.65	15.14	6.17	5.61	1.68	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.24	28.71	13.33	11.45	9.23	8.54	0.00	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	49.41	19.51	14.40	9.85	8.75	6.93	1.28	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.82	20.72	10.55	11.77	7.97	10.42	2.21	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.46	21.22	15.85	13.16	9.00	9.67	1.61	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.28	15.33	15.57	10.38	9.20	5.43	1.65	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.23	23.41	13.49	9.72	7.94	6.55	1.59	3.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.03	24.55	11.69	14.26	6.08	10.29	0.70	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.09	15.76	14.93	10.37	10.58	4.56	0.83	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	53.75	22.34	11.06	13.05	10.18	12.61	1.33	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.16	20.68	15.25	13.16	7.73	11.07	1.04	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	44.55	19.92	16.15	11.17	11.17	5.79	1.35	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	56.71	30.14	15.16	16.86	11.41	7.83	1.19	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	45.69	26.80	11.76	13.50	9.45	10.03	0.96	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	42.30	16.33	13.58	9.97	11.00	6.36	0.86	3.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	51.44	28.39	12.89	13.44	10.01	12.07	1.37	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	51.38	26.76	14.12	12.15	10.51	10.34	1.31	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	45.68	15.34	15.00	8.52	6.14	4.09	1.02	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.98	21.01	11.69	14.20	7.84	9.32	1.18	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	52.24	18.39	11.20	14.39	9.06	12.26	0.80	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	58.07	14.38	13.55	12.44	5.67	5.53	2.07	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	46.67	14.05	10.95	11.43	5.95	10.24	1.19	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	64.29	29.83	13.91	15.72	9.88	13.50	1.01	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	43.41	10.92	9.79	8.19	5.09	4.99	0.85	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	72.32	27.25	12.93	13.63	6.99	11.53	2.79	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	65.58	29.01	16.02	15.72	13.30	14.51	1.21	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.12	12.24	11.63	7.10	4.65	3.92	1.84	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.80	55.31	33.33	24.31	14.12	27.07	2.18	6.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	63.88	17.64	19.47	12.78	6.69	9.73	1.83	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	37.07	8.74	11.75	8.74	3.92	4.22	2.11	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	51.57	19.90	15.61	13.35	6.79	13.35	2.26	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	71.29	22.17	27.86	13.48	8.39	19.17	3.29	3.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.36	22.20	15.35	8.03	7.08	4.49	1.53	3.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	53.36	29.88	16.44	11.53	9.18	12.38	1.71	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	82.93	32.45	22.24	19.83	9.62	29.45	2.40	3.61
Schwann Cells, donor1	11498-119F4	11.10	5.83	3.57	4.14	2.26	1.13	0.38	0.56
Schwann Cells, donor2	11578-120F3	13.61	6.80	13.61	3.40	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.44	10.52	5.04	4.16	6.79	3.29	0.44	0.22
Sebocyte, donor1	11220-116B5	13.69	8.76	2.74	6.57	2.19	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	7.81	4.14	0.92	4.60	2.30	1.84	0.00	0.00
Sebocyte, donor3	11378-118B1	10.31	3.50	1.65	3.30	1.24	2.27	0.21	0.21
Sertoli Cells, donor1	11255-116F4	23.19	14.91	1.66	9.94	4.97	8.28	1.66	1.66
Sertoli Cells, donor2	11333-117F1	33.89	19.77	5.65	8.47	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.19	23.93	11.44	7.13	8.89	8.01	0.62	2.20
Skeletal Muscle Cells, donor2	11358-117H8	10.12	9.40	5.06	4.34	4.34	2.17	1.45	2.89
Skeletal Muscle Cells, donor3	11430-118G8	14.21	6.69	4.18	9.20	3.34	2.51	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	30.63	9.90	5.97	12.57	5.18	2.98	0.31	1.41
Skeletal Muscle Cells, donor5	11455-119A6	27.95	15.90	5.95	13.23	5.20	2.97	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	35.40	14.47	6.77	11.85	5.23	2.31	0.00	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.90	19.28	7.06	9.20	6.05	7.43	0.00	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.53	14.41	4.28	11.84	5.28	7.13	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.00	20.54	9.52	16.17	7.04	8.83	0.30	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	26.96	33.03	13.73	9.27	14.74	5.31	0.84	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	6.51	2.90	5.79	2.90	2.90	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.94	6.88	3.30	3.58	3.72	1.65	0.28	0.83
Skin - palm, donor1	10286-104F7	53.72	18.80	8.06	13.43	5.37	18.80	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.50	3.46	1.30	2.45	0.86	2.31	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.98	13.09	13.09	5.73	12.27	6.54	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.87	3.12	1.04	1.95	1.17	1.95	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	13.90	5.56	3.61	2.09	1.81	3.75	0.14	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	23.07	10.13	4.92	5.34	5.06	3.66	0.14	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	69.78	25.58	8.03	17.34	8.03	8.46	0.85	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	17.09	4.65	6.22	3.75	1.65	6.67	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.10	2.16	1.54	1.85	2.16	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.34	3.11	2.45	4.45	3.33	1.56	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	4.11	0.59	4.70	2.94	2.35	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.71	22.98	4.64	3.98	1.55	1.77	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	2.76	0.39	2.36	1.97	1.18	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	5.41	2.32	3.09	2.32	2.32	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	12.01	3.00	3.00	5.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.85	4.79	1.20	2.26	3.19	1.60	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.86	6.43	1.11	4.43	3.77	1.99	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.11	5.76	1.92	3.97	2.94	2.05	0.26	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.21	17.91	10.74	7.16	7.49	5.54	1.30	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.61	17.72	6.50	10.34	6.79	2.95	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.23	10.82	4.98	6.41	5.13	3.99	0.00	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.65	5.86	1.14	3.74	2.28	1.63	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.31	16.44	7.31	9.74	7.92	3.04	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.40	9.34	2.27	6.82	2.78	2.53	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	30.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	3.34	0.48	2.86	1.43	1.91	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.76	13.27	5.31	7.08	3.69	4.72	0.00	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.16	12.70	4.09	6.24	3.23	2.80	0.65	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	21.10	9.87	4.83	7.87	3.46	5.56	0.21	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.26	4.33	1.70	2.47	2.63	1.24	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	2.16	0.00	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.06	4.48	3.59	5.08	1.49	1.20	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	7.85	3.07	3.76	2.05	1.37	0.34	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.87	14.61	5.42	6.91	3.93	5.89	0.16	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.15	5.64	1.51	3.12	1.81	2.21	0.00	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.02	11.38	4.55	4.78	3.87	1.59	0.46	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	1.21	1.21	1.21	0.00	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.94	13.25	6.36	11.13	3.71	3.18	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	20.64	8.79	4.79	9.99	4.53	3.06	0.40	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.90	7.14	2.75	4.01	3.13	2.63	0.25	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.41	8.88	1.27	3.55	3.04	2.03	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.34	10.55	3.17	6.63	3.62	3.17	0.15	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	8.25	0.75	6.00	5.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	27.14	14.21	5.17	3.88	1.29	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	12.56	2.79	5.12	1.40	1.40	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	2.52	1.01	2.52	2.52	1.01	0.00	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.78	3.76	1.25	3.13	1.88	0.31	0.31	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.78	4.13	1.18	2.95	2.06	1.18	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	34.07	18.16	5.66	11.50	4.00	3.33	0.25	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.23	13.55	2.34	5.14	4.20	4.67	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.61	3.45	0.72	1.73	1.01	1.01	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.71	3.31	2.04	2.80	2.29	2.04	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	2.63	0.75	2.44	0.94	1.50	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.40	9.64	4.05	7.55	2.52	3.07	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.43	10.72	3.60	6.95	3.18	3.60	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.48	0.48	0.00	0.00	3.33	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	5.14	0.98	2.45	2.20	0.98	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.81	7.73	2.43	5.08	4.20	0.88	0.00	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.53	2.34	1.46	2.93	1.17	1.46	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.27	14.58	1.17	3.50	3.30	2.33	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	8.46	2.64	2.91	1.85	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	5.58	0.74	3.35	3.72	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	8.62	2.87	3.23	2.52	2.16	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.38	7.67	3.12	1.70	3.97	1.42	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.00	9.06	3.54	4.73	2.36	1.58	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	15.24	5.59	1.52	3.81	2.03	0.76	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	24.76	6.39	2.00	4.39	2.40	1.60	0.00	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	4.60	2.51	5.43	0.42	1.25	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	15.58	8.25	4.13	5.96	3.67	2.29	0.46	1.38
Synoviocyte, donor1	11291-117A4	20.87	18.52	6.06	7.24	7.41	2.36	0.17	1.01
Synoviocyte, donor2	11368-117I9	15.92	7.71	1.17	6.87	2.85	2.51	0.67	0.67
Synoviocyte, donor3	11440-118H9	17.43	5.36	1.12	3.80	2.23	1.79	0.45	3.13
Trabecular Meshwork Cells, donor1	11532-120A2	15.01	8.93	3.22	5.00	1.07	2.50	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	11.89	5.95	0.00	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	12.04	3.94	7.64	3.01	2.55	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	9.32	3.23	1.36	3.15	0.50	2.01	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	2.32	1.55	0.39	0.77	2.32	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	1.72	0.57	0.57	0.57	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	67.79	51.18	16.36	24.48	12.55	16.85	1.60	3.57
Urethra, donor2	10319-105A4	23.38	12.59	1.80	1.80	5.40	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.64	2.39	1.59	3.19	0.00	2.39	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.01	2.80	0.00	1.20	0.80	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	7.33	2.29	1.15	2.75	0.46	2.52	0.00	0.00
Urothelial cells, donor0	11216-116B1	15.83	5.13	4.46	3.79	2.67	6.69	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	86.31	21.35	17.80	15.13	8.90	9.79	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	101.50	28.59	17.16	15.73	10.01	20.01	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	50.65	23.27	13.69	15.74	5.48	19.17	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	61.98	23.76	11.02	11.71	5.51	18.25	0.69	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	73.21	23.24	15.69	9.88	4.07	15.69	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	111.41	23.95	14.58	23.95	5.21	14.58	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	101.87	15.60	13.77	20.19	10.10	12.85	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	49.30	19.17	9.13	11.87	2.74	12.78	4.56	0.91
Wilms' tumor cell line:G-401	10809-111A8	18.01	11.10	3.58	6.04	5.92	7.15	0.86	1.48
Wilms' tumor cell line:HFWT	10597-108E3	28.16	3.52	9.68	5.28	3.52	18.48	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.32	1.96	8.38	3.91	2.23	12.01	0.84	0.84
achilles tendon, donor2	10292-104G4	45.46	18.60	8.27	2.07	8.27	6.20	6.20	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	15.30	4.59	2.55	4.84	2.55	3.31	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	17.65	8.36	1.39	3.95	2.79	2.09	0.00	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	40.24	20.30	4.27	14.36	6.05	6.17	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	8.98	4.08	1.90	3.54	1.36	1.09	0.27	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.49	12.09	3.37	10.68	3.37	4.22	0.56	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	27.92	9.73	3.81	6.77	2.33	6.13	0.42	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	56.35	21.50	7.89	15.52	7.35	10.89	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	26.88	15.86	8.81	11.90	3.97	6.61	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	7.76	5.72	7.76	3.27	9.39	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	34.95	15.92	4.27	11.26	5.05	6.21	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	30.18	5.15	2.94	7.18	2.02	5.34	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	19.50	7.80	19.50	3.90	19.50	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	14.18	7.90	1.39	4.65	2.79	2.79	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	35.21	9.84	6.99	7.77	4.40	10.87	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	56.40	14.03	9.94	13.15	4.68	10.23	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.24	5.58	4.65	14.41	2.79	5.58	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	38.37	18.42	4.30	6.14	2.76	7.37	0.92	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	44.80	29.02	9.39	17.92	4.69	15.36	1.28	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	53.38	20.02	13.95	13.95	8.19	13.34	0.61	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	63.06	25.03	14.68	15.41	8.42	12.28	1.93	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.93	2.23	2.67	3.56	0.89	2.00	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	32.35	18.01	17.34	7.34	5.67	12.34	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	83.62	13.01	13.01	18.58	7.43	16.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.86	9.42	4.52	7.53	2.64	4.90	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	55.82	45.36	12.65	20.50	15.26	10.03	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	5.62	3.75	7.50	11.25	15.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	2.83	0.94	0.47	0.47	0.24	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	77.87	71.67	15.98	25.75	17.06	12.25	1.09	2.33
adipose, donor1	10184-103D4	48.09	24.04	26.39	16.42	7.62	16.42	1.17	1.17
adipose, donor2	10185-103D5	20.68	8.11	5.68	3.24	3.24	13.79	1.62	0.41
adipose, donor3	10186-103D6	31.31	20.15	20.69	9.80	8.71	10.62	3.27	2.72
adipose, donor4	10187-103D7	32.94	8.67	75.41	6.93	4.33	16.47	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.67	7.58	8.68	6.63	3.16	17.20	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	29.10	3.64	3.64	3.64	18.19	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.08	2.93	4.40	3.87	0.67	4.54	0.27	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.08	7.15	0.71	2.86	2.14	1.79	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	26.89	5.80	1.85	5.80	3.25	3.48	0.23	1.39
amniotic membrane cells, donor2	12236-129G4	30.43	13.86	8.45	11.50	2.70	4.40	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	22.68	3.54	0.88	2.95	0.88	3.54	0.00	0.29
amygdala - adult, donor10196	10167-103B5	90.12	73.52	37.95	49.80	35.57	4.74	9.49	3.56
amygdala, adult, donor10252	10151-102I7	190.20	247.78	101.59	108.68	110.91	15.21	43.80	6.29
amygdala, newborn, donor10223	10360-105E9	31.31	47.12	18.72	11.94	20.01	5.16	5.49	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	35.53	31.32	22.41	13.24	8.66	10.44	2.29	2.80
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	34.64	16.77	11.91	11.03	11.47	6.40	3.97	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	15.70	2.34	0.67	1.67	2.34	4.01	0.00	0.00
aorta, adult, pool1	10052-101G7	40.21	16.08	6.28	11.57	6.08	7.45	1.37	0.59
appendix, adult	10189-103D9	41.14	31.05	12.03	16.30	7.76	12.42	0.39	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.03	0.00	1.38	0.34	0.00	2.06	0.00	0.00
artery, adult	10190-103E1	118.21	84.24	17.66	27.17	28.53	8.15	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	60.84	47.37	23.61	19.27	12.46	10.43	1.45	2.61
b cell line:RPMI1788	10427-106D4	15.76	3.27	3.87	3.57	0.74	8.92	0.15	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.09	9.99	3.33	4.72	2.77	3.05	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.11	7.05	2.98	3.57	1.39	2.28	0.30	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	15.40	3.35	4.85	1.67	2.18	5.02	0.33	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	44.74	11.18	12.86	7.27	3.36	3.36	1.68	0.56
bladder, adult, pool1	10011-101C2	57.04	26.51	10.86	16.73	7.71	14.12	0.65	2.50
blood, adult, pool1	10053-101G8	37.65	11.07	6.64	8.86	0.00	13.29	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	39.39	17.98	4.28	17.13	12.85	1.71	0.00	0.86
bone marrow, adult	10192-103E3	59.38	48.59	19.57	24.29	15.52	7.42	1.35	1.35
brain, adult, donor1	10084-102B3	99.43	124.03	48.18	60.48	72.78	3.08	12.30	11.28
brain, adult, pool1	10012-101C3	140.98	199.67	77.84	70.94	85.30	9.02	12.03	5.01
brain, fetal, pool1	10085-102B4	42.74	80.14	16.03	32.06	18.70	8.01	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	20.48	12.55	4.96	3.63	3.63	2.97	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	8.86	0.50	1.25	1.37	0.12	2.62	0.00	0.12
breast, adult, donor1	10080-102A8	54.93	29.04	6.31	19.57	8.84	4.42	1.26	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.85	3.81	2.29	5.84	2.16	4.32	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	7.73	0.93	0.00	1.24	0.62	1.24	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.36	1.61	0.23	1.84	0.92	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	1.45	0.73	2.66	0.48	1.94	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.47	0.00	0.94	0.00	0.94	1.41	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	10.94	4.16	2.95	2.30	0.98	2.08	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	19.65	10.14	6.02	6.02	2.22	7.29	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.96	6.65	4.26	7.45	3.99	10.11	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	135.86	102.47	69.08	49.51	82.90	2.30	14.97	6.91
caudate nucleus, adult, donor10252	10164-103B2	158.29	178.20	69.44	85.00	75.30	13.55	22.25	3.68
caudate nucleus, adult, donor10258	10379-105H1	82.53	92.46	32.09	41.26	49.67	5.35	3.82	2.29
caudate nucleus, newborn, donor10223	10354-105E3	77.28	108.04	42.12	26.00	41.02	6.59	12.45	5.86
cerebellum - adult, donor10196	10173-103C2	84.48	69.92	29.13	46.61	32.05	11.65	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	111.03	142.20	55.94	59.36	48.68	20.92	22.42	5.12
cerebellum, adult, pool1	10083-102B2	41.05	59.33	15.18	26.22	27.94	4.48	7.24	3.10
cerebellum, newborn, donor10223	10357-105E6	65.59	128.69	57.29	24.91	50.65	18.27	12.45	4.98
cerebral meninges, adult	10188-103D8	102.37	151.54	47.65	47.91	62.03	12.86	3.78	4.29
cerebrospinal fluid, donor2	10294-104G6	67.97	78.20	41.66	33.62	40.93	5.12	4.39	3.65
cervical cancer cell line:D98-AH2	10552-107I3	17.69	5.75	6.61	5.03	1.29	9.20	0.00	1.15
cervical cancer cell line:ME-180	10553-107I4	18.39	7.13	7.62	4.64	5.14	4.97	0.00	0.66
cervix, adult, pool1	10013-101C4	60.68	43.05	11.34	19.84	9.76	12.49	0.84	4.30
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.07	35.25	12.40	9.89	13.93	8.08	0.70	2.79
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	18.29	13.06	7.84	13.06	10.45	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	37.41	10.31	21.87	8.20	3.73	13.42	0.99	0.99
choriocarcinoma cell line:SCH	10785-110H2	46.70	21.19	32.40	10.10	8.62	20.82	1.11	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	35.34	4.03	15.18	9.72	2.13	14.47	0.47	2.61
chorionic membrane cells, donor1	12238-129G6	32.48	8.55	4.84	8.26	3.13	5.98	0.85	2.56
chorionic membrane cells, donor2	12239-129G7	32.02	19.39	5.77	11.73	6.36	5.87	0.10	1.09
chorionic membrane cells, donor3	12240-129G8	51.10	9.34	6.59	9.89	2.75	6.04	0.00	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	11.11	5.05	0.00	3.03	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	44.18	24.01	6.34	15.37	8.64	4.23	1.34	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	28.30	7.60	3.17	4.22	2.32	8.66	0.21	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	53.16	9.24	12.07	11.81	3.85	13.87	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.12	9.92	16.93	13.79	3.63	17.66	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	54.57	13.03	17.51	13.85	4.28	17.10	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	40.05	17.67	14.13	10.89	4.12	13.54	0.00	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.20	30.23	14.33	19.29	7.56	16.94	0.52	4.69
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.60	4.34	5.03	5.26	1.14	7.77	0.69	1.37
clear cell carcinoma cell line:TEN	10636-108I6	13.88	7.11	4.51	3.47	1.56	6.77	0.69	0.69
colon carcinoma cell line:CACO-2	10513-107D9	16.47	6.59	8.05	5.31	1.10	9.70	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	7.14	10.71	1.19	5.95	2.38	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	38.54	29.38	9.52	11.28	6.35	8.46	1.29	1.88
colon, fetal, donor1	10070-101I7	19.78	14.83	1.85	8.03	4.94	11.12	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	183.34	178.76	32.08	91.67	36.67	59.59	18.33	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.99	16.15	5.95	4.67	4.25	8.07	0.42	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.68	8.45	1.06	4.68	1.66	4.23	0.15	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	19.88	5.08	2.12	4.37	0.99	3.67	0.00	1.83
corpus callosum, adult, pool1	10042-101F6	379.89	671.89	231.41	218.69	341.64	23.77	38.37	13.49
cruciate ligament, donor2	10295-104G7	46.20	25.94	8.10	11.35	12.16	7.29	2.43	4.05
diaphragm, fetal, donor1	10069-101I6	66.61	53.77	4.82	20.06	16.05	3.21	0.80	4.82
diencephalon, adult	10193-103E4	190.55	244.31	94.80	108.71	191.51	10.56	18.48	6.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	20.44	6.66	2.30	5.51	2.76	4.59	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.59	6.67	8.46	4.36	2.05	9.23	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.13	7.22	2.41	5.30	1.93	5.06	0.24	0.24
ductus deferens, adult	10196-103E7	37.87	18.94	6.98	7.97	4.49	4.98	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	10.08	2.88	2.88	2.88	4.32	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	31.63	20.60	14.71	7.36	10.30	7.36	1.47	0.00
dura mater, adult, donor1	10041-101F5	88.53	70.12	24.86	25.68	25.44	18.17	1.65	3.55
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.55	11.99	6.88	4.89	6.44	6.22	2.66	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.77	10.03	7.59	5.30	3.30	11.18	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	32.68	10.48	22.20	8.02	7.40	25.28	0.00	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	20.89	5.15	9.99	4.54	2.72	11.50	0.00	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	27.17	10.50	13.89	5.25	5.87	13.89	0.00	0.93
embryonic pancreas cell line:2C6	10603-108E9	53.85	18.39	30.21	5.25	2.63	24.96	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	25.14	6.03	4.02	2.68	1.34	4.36	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	37.33	23.92	13.59	9.42	7.79	14.68	1.27	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.09	0.96	0.96	0.64	0.00	0.96	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	28.57	7.78	7.00	6.11	2.89	8.89	0.33	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.11	9.13	11.99	5.94	2.09	7.59	0.33	1.43
epididymis, adult	10197-103E8	36.21	27.84	10.67	10.26	7.74	7.12	1.05	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.50	9.93	1.95	8.87	2.31	6.92	0.00	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.56	7.86	3.93	6.29	4.33	5.11	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.94	2.36	2.62	2.88	1.31	4.19	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.72	5.02	3.64	3.74	1.77	3.74	0.00	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.77	2.58	2.35	2.91	1.01	4.48	0.22	0.22
esophagus, adult, pool1	10015-101C6	51.81	27.71	8.49	11.36	5.84	7.64	0.64	2.55
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.33	15.90	7.51	10.39	5.39	22.54	1.75	3.88
eye - muscle inferior rectus, donor1	10272-104E2	84.51	53.12	28.97	14.49	19.32	9.66	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	71.54	31.56	25.25	6.31	18.94	10.52	0.00	2.10
eye - muscle medial, donor2	10299-104H2	58.04	53.58	28.28	19.35	22.32	13.39	0.00	4.46
eye - muscle superior, donor2	10297-104G9	65.35	49.30	26.37	19.49	20.64	6.88	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	16.03	14.57	10.20	10.20	11.66	2.91	4.37
eye, fetal, donor1	10054-101G9	33.81	24.66	12.20	14.49	7.88	7.88	1.27	3.56
fibrosarcoma cell line:HT-1080	10758-110E2	30.90	7.57	3.46	8.21	3.08	4.62	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.68	13.06	4.51	10.21	5.22	5.70	0.47	0.95
frontal lobe, adult, pool1	10040-101F4	134.26	229.59	70.65	75.06	107.62	7.51	9.38	4.88
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.61	6.31	21.62	3.00	2.70	14.11	0.60	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	31.00	18.38	9.88	10.06	5.94	8.14	0.46	1.19
gall bladder, adult	10198-103E9	41.53	20.04	10.14	8.93	9.17	8.69	0.24	1.69
gamma delta positive T cells, donor1	11937-126A2	34.90	12.88	5.91	6.98	2.68	6.44	1.07	3.22
gamma delta positive T cells, donor2	11938-126A3	36.60	23.53	7.47	7.47	3.73	12.70	2.61	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.43	6.34	3.38	5.07	4.44	2.96	0.63	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.80	3.29	3.09	1.55	0.77	1.93	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	33.28	14.59	8.85	11.64	8.03	12.46	0.16	0.82
gastric cancer cell line:GSS	10560-108A2	3.66	0.00	0.92	0.00	0.00	7.32	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	4.57	1.83	3.88	1.37	0.91	6.17	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	12.28	1.84	4.36	1.49	0.11	6.54	0.00	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	25.61	6.58	3.22	8.40	1.12	8.26	0.00	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.97	1.25	2.00	1.50	1.00	2.24	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.68	16.99	3.17	6.44	7.18	2.11	0.00	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	19.66	18.54	2.81	8.15	7.44	2.25	0.00	0.84
glioblastoma cell line:T98G	10485-107A8	29.69	17.99	2.98	9.71	4.53	2.10	0.00	0.22
glioma cell line:GI-1	10413-106B8	27.82	18.16	12.30	8.20	5.56	5.56	1.46	1.76
globus pallidus - adult, donor10196	10175-103C4	152.34	177.13	63.42	62.69	95.49	7.29	25.51	7.29
globus pallidus, adult, donor10252	10161-103A8	344.42	524.07	250.93	208.94	284.37	31.73	94.22	13.43
globus pallidus, adult, donor10258	10367-105F7	231.40	234.13	149.24	87.63	123.23	26.01	26.01	8.22
globus pallidus, newborn, donor10223	10364-105F4	107.12	130.56	57.56	38.37	75.14	10.13	13.32	6.40
granulocyte macrophage progenitor, donor1	12131-128D7	305.89	274.08	88.10	119.91	85.65	70.97	14.68	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	21.86	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	5.23	5.23	5.23	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.76	7.36	10.24	10.56	6.72	8.32	0.64	2.24
hIPS +CCl2, biol_rep1	14383-156B9	31.22	9.18	20.66	13.31	1.84	6.43	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	28.81	11.43	16.00	10.52	5.49	6.86	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	27.05	5.80	14.17	6.44	5.15	2.58	0.64	0.64
hIPS, biol_rep1	14380-156B6	28.75	1.44	5.75	10.06	4.31	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	26.06	3.43	18.52	8.23	3.43	7.54	0.00	0.00
hIPS, biol_rep3	14382-156B8	122.48	98.21	57.38	71.73	69.52	6.62	8.83	3.31
hairy cell leukemia cell line:Mo	10712-109I1	9.77	0.29	0.29	4.88	0.00	3.16	0.57	0.29
heart - mitral valve, adult	10205-103F7	75.34	83.41	21.53	23.92	34.98	9.87	3.29	3.29
heart - pulmonic valve, adult	10206-103F8	105.90	120.80	25.36	40.53	37.13	12.55	2.61	3.92
heart - tricuspid valve, adult	10207-103F9	104.08	99.92	25.81	36.64	24.15	20.82	9.16	20.82
heart, adult, diseased post-infarction, donor1	10050-101G5	41.42	30.40	9.79	15.51	10.20	5.92	0.61	1.43
heart, adult, diseased, donor1	10051-101G6	60.47	60.04	16.61	24.70	19.59	5.11	1.28	2.98
heart, adult, pool1	10016-101C7	123.50	149.72	26.68	48.07	42.09	11.04	1.84	8.05
heart, fetal, pool1	10046-101G1	268.82	297.87	116.64	96.93	57.71	31.32	14.99	5.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.21	6.79	4.01	5.55	0.93	4.63	0.31	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	7.14	2.38	9.51	2.38	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.93	28.73	13.37	15.91	9.39	17.13	2.32	1.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	36.53	29.74	12.74	16.75	12.02	15.78	2.43	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.75	30.21	11.92	16.17	13.44	16.98	2.73	1.52
hepatoma cell line:Li-7	10484-107A7	40.26	28.03	15.79	11.68	6.23	4.45	1.22	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	15.58	3.22	2.81	3.82	1.51	4.52	0.30	0.50
hippocampus - adult, donor10196	10169-103B7	99.36	85.17	52.05	54.89	40.69	2.84	10.41	3.79
hippocampus, adult, donor10252	10153-102I9	260.02	336.56	133.07	141.24	135.93	19.80	53.88	7.55
hippocampus, adult, donor10258	10374-105G5	92.62	49.80	47.31	39.34	54.77	4.48	8.96	2.49
hippocampus, newborn, donor10223	10363-105F3	32.43	42.30	16.57	11.28	15.51	5.99	4.93	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.97	10.38	15.26	4.27	1.22	17.70	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.78	7.66	7.66	3.73	2.36	11.00	0.79	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.55	11.43	6.86	4.82	2.03	14.47	1.02	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.14	11.84	15.22	14.10	4.51	9.59	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.12	16.27	18.59	15.49	7.49	12.91	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.24	16.32	20.50	10.25	3.04	8.35	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	43.50	33.28	16.06	10.80	15.47	2.92	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.13	40.29	25.21	17.23	12.93	14.43	3.02	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.11	42.54	17.93	9.59	15.43	7.92	3.34	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.12	59.20	22.50	16.34	26.05	10.66	2.37	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.68	53.36	20.09	12.54	19.45	10.29	5.30	2.57
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.70	52.52	18.85	15.49	25.59	9.43	3.37	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	19.40	5.95	4.69	7.04	2.19	9.70	0.78	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	17.20	5.40	7.37	5.40	1.47	6.88	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	11.35	2.62	6.11	4.36	2.62	6.11	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	48.87	18.52	12.60	11.65	6.68	11.45	0.57	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	33.14	10.03	13.08	13.95	5.67	6.54	1.31	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.99	11.99	13.49	10.00	6.00	6.00	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.80	6.97	13.75	6.59	4.52	14.69	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.92	5.91	10.46	10.00	4.09	10.00	1.36	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	19.42	8.14	12.53	4.70	3.76	15.04	1.88	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	15.68	9.47	7.02	6.86	5.39	2.94	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.52	13.06	12.19	6.39	12.48	4.06	3.48	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	15.54	17.34	13.15	5.68	7.77	10.16	2.09	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	20.51	7.21	7.76	6.47	2.77	12.38	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.54	5.14	8.84	5.42	4.56	8.27	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	20.82	11.02	21.64	4.49	4.49	15.52	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.93	11.97	11.27	6.69	3.52	9.51	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	8.24	6.02	6.33	2.53	5.07	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.30	7.87	7.87	6.96	2.12	5.45	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.27	12.93	8.79	4.65	2.07	4.14	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.26	8.63	3.32	5.31	5.98	8.63	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.09	12.31	6.93	3.59	3.33	7.44	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.84	18.66	8.69	9.71	8.69	5.37	1.28	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	17.42	5.30	8.33	13.63	6.82	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.45	15.46	7.39	4.37	5.38	4.37	0.67	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	19.08	7.97	7.00	5.80	4.11	7.73	1.45	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	7.58	12.92	3.57	2.23	11.59	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.00	6.34	10.73	6.34	2.93	11.71	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.34	18.03	14.98	12.22	6.72	9.47	1.22	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	104.10	65.06	84.58	32.53	29.28	29.28	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.07	14.23	17.87	13.57	4.63	11.58	0.66	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	55.28	31.20	24.08	9.30	13.14	13.68	2.19	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	31.85	18.46	21.35	11.22	8.69	11.22	1.81	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.23	33.45	19.93	9.25	8.54	18.15	3.20	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	28.64	38.19	8.35	7.16	13.13	9.55	4.77	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	49.70	52.00	29.25	19.23	17.47	9.75	4.88	3.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.86	25.32	15.36	7.27	9.70	9.43	2.42	2.16
immature langerhans cells, donor1	11904-125F5	81.60	37.53	45.77	23.00	18.89	16.95	5.57	14.29
immature langerhans cells, donor2	11905-125F6	68.92	22.18	28.52	7.92	11.09	15.84	6.34	7.92
insula, adult, pool1	10039-101F3	134.00	227.31	69.65	67.85	101.26	13.53	10.13	4.54
keratoacanthoma cell line:HKA-1	10791-110H8	9.75	1.30	1.30	3.58	0.65	1.63	0.00	0.33
kidney, adult, pool1	10017-101C8	34.44	27.13	10.41	8.81	7.61	8.21	0.50	1.60
kidney, fetal, pool1	10045-101F9	53.97	54.47	20.23	20.87	14.93	17.19	1.77	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.95	3.98	2.41	3.12	1.14	3.83	0.14	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.34	2.90	1.38	1.80	0.97	0.14	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.39	8.07	16.15	4.95	3.12	21.47	0.73	2.57
left atrium, adult, donor1	10079-102A7	43.04	34.33	11.99	9.26	12.53	3.27	0.54	2.18
left ventricle, adult, donor1	10078-102A6	43.99	43.49	9.61	16.18	16.18	5.56	1.52	2.02
leiomyoblastoma cell line:G-402	10721-110A1	44.05	61.84	21.34	19.43	24.62	8.76	1.37	0.55
leiomyoma cell line:10964C	10569-108B2	6.47	0.72	1.44	2.87	0.72	0.36	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	5.43	1.63	1.09	0.00	2.72	1.09	0.00	0.54
leiomyoma cell line:15425	10571-108B4	10.44	6.80	0.97	2.67	1.94	0.97	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	31.37	14.64	5.23	8.36	7.32	8.36	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	36.01	5.31	9.09	8.62	1.30	14.76	0.71	1.06
liposarcoma cell line:KMLS-1	10782-110G8	22.03	11.40	2.97	7.65	6.56	3.12	0.31	0.62
liposarcoma cell line:SW 872	10726-110A6	16.20	10.60	5.00	6.21	3.90	4.75	0.24	0.85
liver, adult, pool1	10018-101C9	34.84	18.96	7.78	9.08	2.76	6.81	0.32	0.49
liver, fetal, pool1	10086-102B5	12.23	2.82	2.82	2.82	0.00	3.76	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	165.66	266.13	126.14	79.04	141.60	16.48	18.96	9.62
locus coeruleus, adult, donor10252	10165-103B3	204.67	303.22	147.27	126.05	135.28	19.19	52.41	9.04
locus coeruleus, adult, donor10258	10375-105G6	106.37	121.04	40.06	44.01	71.38	8.75	11.00	4.51
locus coeruleus, newborn, donor10223	10362-105F2	57.20	104.73	46.27	21.03	45.01	10.09	8.83	2.10
lung adenocarcinoma cell line:A549	10499-107C4	14.95	3.18	2.08	2.08	0.69	2.08	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	10.34	2.76	0.00	3.45	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	34.01	7.12	4.09	7.78	2.64	3.03	0.26	0.13
lung, adult, pool1	10019-101D1	75.25	56.23	24.10	24.69	11.81	17.72	2.01	5.43
lung, fetal, donor1	10068-101I5	141.85	90.47	57.65	41.10	39.39	21.98	4.57	12.56
lung, right lower lobe, adult, donor1	10075-102A3	55.44	42.16	9.62	17.41	8.25	7.33	1.37	7.79
lymph node, adult, donor1	10077-102A5	31.24	18.93	8.05	7.10	6.15	2.84	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	18.87	6.49	1.81	6.94	1.96	1.21	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	19.54	11.04	22.94	2.55	4.25	15.29	0.00	0.00
mature adipocyte, donor1	12231-129F8	151.40	142.08	13.32	42.18	39.96	5.77	2.22	2.66
mature adipocyte, donor2	12232-129F9	134.89	120.99	18.89	35.49	41.09	9.34	4.77	4.98
mature adipocyte, donor3	12233-129G1	113.79	87.48	15.65	37.22	32.48	6.64	2.84	3.32
mature adipocyte, donor4	12234-129G2	105.02	91.34	10.00	41.85	38.17	3.95	2.37	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	29.31	8.34	8.10	6.19	2.38	8.58	0.24	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	64.30	67.68	47.38	29.33	34.97	7.90	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	155.95	214.43	85.15	88.09	101.70	17.84	38.99	4.78
medial frontal gyrus, adult, donor10258	10368-105F8	59.09	78.47	23.83	29.23	42.25	1.27	7.94	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	39.66	56.72	48.62	12.37	20.90	8.10	6.40	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	81.51	100.41	48.09	38.98	48.60	6.24	9.28	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	196.52	265.07	105.26	102.50	130.52	17.40	44.57	4.46
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	59.71	25.04	44.30	40.45	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	373.19	157.89	143.54	86.12	0.00	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	19.38	30.87	14.72	8.26	15.08	7.18	4.31	0.36
medulla oblongata - adult, donor10196	10174-103C3	92.15	101.89	60.35	42.18	51.27	9.09	10.38	2.60
medulla oblongata, adult, donor10252	10155-103A2	207.75	260.53	139.32	113.32	123.84	23.84	59.75	10.22
medulla oblongata, adult, pool1	10038-101F2	228.23	374.42	147.66	121.30	186.68	21.47	16.24	9.39
medulla oblongata, newborn, donor10223	10361-105F1	111.10	157.97	64.23	43.05	74.30	24.30	21.18	8.33
medulloblastoma cell line:D283 Med	10838-111E1	65.10	11.96	17.71	14.61	5.31	12.62	0.89	3.76
medulloblastoma cell line:ONS-76	10759-110E3	18.34	11.37	4.28	7.58	2.45	5.50	0.12	0.73
melanoma cell line:COLO 679	10514-107E1	26.59	22.28	11.93	12.07	7.47	5.75	0.14	0.72
melanoma cell line:G-361	10465-106H6	11.67	6.52	2.17	4.07	1.63	3.53	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	24.06	8.68	7.06	4.88	3.62	4.70	0.54	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	5.29	6.17	4.41	1.76	7.93	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	9.59	5.96	12.70	2.85	2.33	10.37	1.56	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.63	11.66	2.45	9.05	5.06	1.38	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.72	18.36	3.27	9.27	7.63	3.27	1.27	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	10.35	2.90	6.21	7.04	1.66	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.78	8.43	3.65	4.64	2.53	1.83	0.14	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.48	7.51	3.08	6.35	3.85	1.16	0.19	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	10.41	4.86	6.25	2.08	4.16	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	4.63	2.57	2.06	1.37	1.20	0.86	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.85	14.03	4.60	7.59	3.80	2.42	0.35	1.50
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.58	9.42	1.99	4.91	3.98	1.46	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.45	9.86	1.89	5.13	3.11	1.35	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.05	15.79	4.27	7.68	5.55	1.99	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.83	9.22	4.28	1.65	2.96	2.31	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	26.84	11.62	4.29	8.44	4.15	2.77	0.14	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.45	8.38	1.75	8.38	2.44	2.09	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.47	6.33	3.27	4.90	1.63	2.04	0.20	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.22	6.47	5.39	3.59	5.75	5.03	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.28	6.41	3.93	6.10	2.59	2.28	0.62	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	5.47	2.96	2.96	3.65	1.82	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	18.46	10.91	5.45	4.62	4.20	3.36	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.43	10.01	4.48	6.87	3.74	2.09	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.24	11.90	5.34	6.74	4.99	2.71	0.18	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	14.73	3.68	1.84	2.21	1.47	5.89	0.37	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	9.16	2.86	3.43	4.58	4.58	0.29	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.42	14.31	8.84	12.63	6.32	5.05	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.35	6.85	2.74	4.11	5.94	3.65	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.60	9.21	2.56	7.42	2.56	2.81	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	10.21	3.40	6.81	3.66	1.83	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	10.17	5.55	4.01	3.08	3.08	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.36	10.59	2.59	6.59	4.94	3.29	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	13.54	3.38	5.75	6.09	2.37	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.33	8.65	2.75	6.68	3.54	1.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.07	9.27	3.71	4.17	1.39	4.17	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	96.61	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.57	14.13	3.75	6.35	3.17	2.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.42	12.72	3.57	6.25	3.57	3.79	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.63	11.30	3.12	4.33	4.57	2.16	0.24	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	18.33	2.93	5.13	8.07	2.20	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.45	11.08	3.02	3.69	5.71	2.35	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	12.69	2.05	2.87	4.09	2.46	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	12.03	2.58	6.87	4.30	1.72	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	2.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	5.16	5.16	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.24	12.67	1.62	4.22	6.17	1.95	0.00	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	5.82	2.91	4.36	2.91	5.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	11.19	1.60	2.67	3.20	3.20	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	12.27	0.82	7.36	3.27	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.55	7.77	3.50	5.44	3.89	2.33	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	14.69	0.00	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	13.91	0.99	8.94	2.98	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	14.30	0.00	0.00	4.77	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.38	13.05	1.19	5.93	4.74	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	18.28	3.66	10.97	2.44	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	13.93	2.53	5.07	3.80	1.90	0.00	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.87	12.42	3.45	7.59	4.48	0.69	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	15.04	6.45	8.60	10.75	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	17.22	3.44	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	10.19	2.04	7.74	5.30	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	13.51	13.51	2.38	6.36	5.56	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	13.56	0.59	5.90	4.72	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	18.08	1.87	4.05	4.68	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	14.70	1.34	5.35	9.36	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	23.65	4.73	8.28	3.55	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	20.54	10.27	5.14	5.14	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	28.22	7.57	7.57	8.95	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	34.64	11.38	11.38	21.28	1.48	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	17.94	7.85	14.58	19.07	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.99	34.35	5.72	7.63	26.08	1.27	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.31	27.00	4.43	6.45	19.75	2.01	0.40	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	30.53	6.54	6.54	19.63	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	15.20	6.34	3.80	19.01	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	29.74	13.96	12.14	15.78	2.43	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	31.63	9.04	22.59	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	32.12	5.77	7.41	15.65	2.47	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.29	20.44	3.37	5.56	7.94	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.36	13.63	1.62	3.89	10.71	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	20.37	4.07	1.02	7.13	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.95	50.29	12.38	16.25	18.57	10.83	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.12	10.63	7.56	9.92	1.89	11.81	0.00	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	25.02	29.19	5.79	15.52	8.34	7.41	1.16	4.40
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	42.74	0.00	29.92	8.55	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.39	15.00	3.39	5.75	6.17	2.98	0.31	0.62
mesothelioma cell line:Mero-25	10850-111F4	20.43	13.39	6.58	5.90	7.04	3.40	0.23	0.91
mesothelioma cell line:Mero-41	10851-111F5	35.45	15.16	5.62	9.05	8.80	8.31	0.73	1.71
mesothelioma cell line:Mero-48a	10852-111F6	23.91	9.52	4.21	6.86	5.76	3.32	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	36.53	25.49	4.99	12.61	10.78	3.68	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	10.55	4.77	2.89	3.40	2.89	3.40	0.51	0.68
mesothelioma cell line:Mero-84	10855-111F9	10.11	5.31	3.03	2.53	2.27	2.02	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	19.25	8.70	4.97	7.66	3.93	4.97	0.41	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	13.75	9.11	2.32	4.47	3.81	2.98	0.17	1.16
mesothelioma cell line:NCI-H226	10846-111E9	17.38	17.01	3.26	9.23	10.50	2.35	0.90	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	38.78	14.18	3.07	9.05	5.12	3.93	0.17	0.85
mesothelioma cell line:NCI-H28	10845-111E8	21.38	16.03	8.40	8.91	12.47	4.58	0.76	0.25
mesothelioma cell line:No36	10857-111G2	8.81	4.89	3.26	2.28	2.61	3.91	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	23.03	11.92	6.50	4.34	4.06	6.50	0.54	1.63
migratory langerhans cells, donor1	11901-125F2	28.79	6.91	6.53	5.95	1.73	8.64	0.38	1.92
migratory langerhans cells, donor2	11902-125F3	35.05	6.59	5.86	6.96	1.71	10.62	0.00	1.10
migratory langerhans cells, donor3	11903-125F4	33.92	6.28	6.28	7.72	1.97	14.00	0.36	2.51
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.91	8.81	18.61	9.79	5.55	21.55	0.98	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.41	6.57	6.78	6.36	1.70	4.45	2.97	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	49.99	23.50	21.65	16.13	10.14	7.83	0.92	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.47	1.71	0.57	0.38	1.14	2.85	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.55	12.38	5.91	9.98	3.33	4.99	0.18	0.74
myeloma cell line:PCM6	10474-106I6	34.99	10.08	2.97	6.72	2.97	2.97	0.00	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	10.15	4.57	6.09	2.03	6.59	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.24	6.47	5.49	9.22	4.90	3.73	1.57	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.59	1.45	1.78	1.89	0.45	4.23	0.11	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.49	1.62	3.60	1.25	0.44	3.38	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	17.11	7.73	16.56	3.31	1.66	3.31	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	15.18	5.52	7.36	4.14	1.38	6.44	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	14.03	5.61	19.64	3.93	2.25	20.95	0.37	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	13.92	3.16	6.75	5.06	2.32	4.43	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	13.98	1.49	6.71	4.10	2.98	14.72	0.93	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.68	6.64	5.93	3.08	4.03	5.69	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.95	11.56	3.01	8.24	4.43	1.74	0.63	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	12.68	5.03	2.82	5.43	1.81	4.03	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	5.09	5.09	3.81	3.81	5.09	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	28.21	16.24	4.26	9.05	6.92	4.52	1.06	0.53
neutrophil PMN, donor1	12133-128D9	267.75	104.12	74.37	0.00	59.50	163.62	44.62	14.87
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	9.47	28.41	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	47.52	8.79	7.10	13.70	2.71	14.21	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2.40	2.40	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.67	13.14	5.45	4.81	10.90	2.89	1.28	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.71	16.82	4.47	7.09	4.99	4.99	0.26	1.05
nucleus accumbens, adult, pool1	10037-101F1	156.64	265.28	76.68	84.74	116.05	11.62	10.59	6.00
occipital cortex - adult, donor10196	10172-103C1	67.99	90.66	72.11	35.03	51.51	10.30	10.30	4.12
occipital cortex, adult, donor10252	10163-103B1	227.04	350.21	120.23	125.06	162.09	21.20	57.70	6.71
occipital cortex, newborn, donor10223	10355-105E4	23.29	32.39	18.20	9.83	13.10	8.01	4.00	1.46
occipital lobe, adult, donor1	10076-102A4	101.55	147.99	45.40	54.84	84.75	5.51	8.92	2.36
occipital lobe, fetal, donor1	10073-102A1	46.77	55.35	17.59	16.73	21.46	9.87	15.88	4.29
occipital pole, adult, pool1	10036-101E9	95.32	167.62	47.94	53.69	84.60	7.33	7.41	3.47
olfactory region, adult	10195-103E6	132.78	163.35	64.00	70.69	97.44	8.79	8.22	4.78
optic nerve, donor1	10277-104E7	344.18	496.26	302.16	164.09	282.15	18.01	74.04	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.86	6.95	6.38	4.21	2.16	4.90	0.34	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	24.18	6.87	11.82	4.95	2.06	17.59	0.69	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.68	2.54	2.71	2.71	0.51	3.39	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.73	5.66	6.58	8.20	2.43	6.70	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	27.04	23.81	7.06	10.58	12.05	6.47	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.01	47.65	4.67	19.62	15.88	4.67	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	30.96	45.17	11.45	12.30	10.39	3.61	0.85	1.06
ovary, adult, pool1	10020-101D2	43.68	29.70	11.62	16.07	6.99	12.67	1.22	3.23
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.83	11.55	8.07	8.25	5.68	4.22	0.92	1.28
pancreas, adult, donor1	10049-101G4	12.23	0.94	0.94	4.70	1.88	3.76	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	49.48	16.49	12.30	8.95	8.39	7.27	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	21.98	12.78	5.28	8.52	6.13	3.24	0.51	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.00	9.77	6.62	5.80	3.48	6.95	0.33	1.66
paracentral gyrus, adult, pool1	10035-101E8	137.28	242.53	81.00	77.98	120.81	13.64	10.71	6.41
parietal cortex, adult, donor10258	10373-105G4	81.47	102.03	63.86	35.23	56.52	3.67	6.61	2.94
parietal lobe - adult, donor10196	10171-103B9	113.80	103.45	76.18	40.44	53.61	11.29	7.52	0.94
parietal lobe, adult, donor10252	10157-103A4	151.64	179.86	74.96	82.66	79.53	15.11	29.93	2.00
parietal lobe, adult, pool1	10034-101E7	139.58	251.32	80.45	81.07	119.14	11.28	14.10	6.43
parietal lobe, fetal, donor1	10072-101I9	84.38	107.65	39.76	34.91	19.40	12.61	9.70	0.97
parietal lobe, newborn, donor10223	10356-105E5	25.80	42.62	22.81	10.84	16.45	7.48	2.62	2.62
parotid gland, adult	10199-103F1	20.97	16.03	9.87	6.78	6.17	2.47	0.00	0.62
penis, adult	10200-103F2	59.08	40.82	10.74	20.95	13.96	11.28	1.61	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	42.39	26.77	42.39	13.95	8.74	51.88	1.12	2.79
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.50	5.10	3.06	3.79	2.19	2.19	0.00	0.73
pineal gland - adult, donor10196	10179-103C8	21.29	14.84	10.32	8.39	7.74	1.29	0.65	2.58
pineal gland, adult, donor10252	10160-103A7	32.57	31.39	17.17	11.84	13.03	5.92	1.18	1.78
pineal gland, adult, donor10258	10377-105G8	30.10	26.96	11.29	6.90	7.52	6.90	0.00	2.51
pituitary gland - adult, donor10196	10180-103C9	11.13	14.17	8.09	4.05	5.06	4.05	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	39.09	18.24	8.86	11.47	5.21	10.42	1.56	2.08
pituitary gland, adult, donor10258	10378-105G9	7.66	6.81	1.70	2.55	0.85	3.40	0.85	1.70
placenta, adult, pool1	10021-101D3	59.77	33.43	17.31	14.94	7.85	15.91	0.32	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	27.54	7.15	6.62	6.75	2.52	5.69	0.00	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.20	26.30	5.45	19.14	13.07	8.25	0.78	0.78
pons, adult, pool1	10033-101E6	159.31	267.84	115.76	89.08	147.09	14.63	14.63	7.57
postcentral gyrus, adult, pool1	10032-101E5	105.92	190.48	58.67	62.07	96.76	8.02	8.11	4.36
promyelocytes/myelocytes PMC, donor1	12132-128D8	190.32	87.84	35.55	54.38	52.28	35.55	6.27	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	5.51	0.00	0.00	5.51	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	20.98	4.22	3.20	3.64	1.31	4.95	0.29	0.87
prostate cancer cell line:PC-3	10439-106E7	32.85	22.32	9.08	11.98	5.81	5.08	0.73	1.09
prostate, adult, pool1	10022-101D4	47.52	27.93	9.07	15.78	7.35	6.44	1.09	2.18
putamen, adult, donor10196	10176-103C5	153.44	156.98	88.29	78.85	74.60	13.46	15.11	4.25
putamen, adult, donor10252	10152-102I8	211.76	290.19	86.27	100.00	135.29	9.80	13.73	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	49.18	24.04	16.39	31.69	32.78	5.46	6.56	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	106.79	129.02	37.21	52.91	71.76	7.25	6.04	3.38
putamen, newborn, donor10223	10365-105F5	50.23	77.22	56.22	14.24	44.98	5.25	17.24	1.50
rectal cancer cell line:TT1TKB	10469-106I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	55.64	23.65	8.35	15.30	6.95	8.35	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	19.08	8.27	1.91	3.82	1.48	2.76	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	0.00	7.04	0.41	0.00	14.50	0.41	0.41
retina, adult, pool1	10030-101E3	50.89	47.41	17.20	19.28	17.30	12.52	1.59	2.88
retinoblastoma cell line:Y79	10475-106I7	11.17	1.82	3.38	2.60	1.04	7.01	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.11	11.07	6.64	7.99	3.81	4.92	0.00	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	90.27	52.30	23.34	34.31	16.59	15.75	0.56	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	41.68	26.52	7.58	12.88	11.37	9.85	0.00	3.79
salivary acinar cells, donor1	11771-123I7	28.00	12.14	5.99	7.61	3.56	2.43	0.49	0.49
salivary acinar cells, donor2	11772-123I8	52.73	33.46	13.91	11.84	10.46	3.03	0.83	2.48
salivary acinar cells, donor3	11773-123I9	86.07	65.54	23.83	22.51	23.83	9.93	0.66	6.62
salivary gland, adult, pool1	10093-102C3	30.31	6.86	6.86	4.58	4.58	1.72	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.82	5.56	5.82	3.71	1.94	6.66	0.59	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.17	7.99	4.47	3.17	2.00	5.05	0.59	0.47
seminal vesicle, adult	10201-103F3	26.45	18.52	7.94	7.41	7.41	3.70	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	5.10	6.80	3.64	3.89	4.62	0.24	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.94	11.07	8.56	6.54	2.77	6.04	0.50	3.02
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	22.08	7.02	10.04	3.01	9.03	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.60	4.03	2.01	2.15	0.81	2.42	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.84	0.90	0.39	1.29	0.39	0.90	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	134.77	65.97	34.76	28.37	36.18	11.35	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	143.92	91.27	20.39	41.98	32.62	8.04	2.28	4.08
skeletal muscle, fetal, donor1	10066-101I3	24.12	16.08	4.02	15.08	8.04	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	33.93	6.79	0.00	0.00	6.79	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	61.23	32.82	10.10	19.57	15.15	11.36	1.26	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	4.34	3.34	1.33	1.33	1.67	3.34	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	5.36	11.66	2.84	3.15	12.29	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.30	6.36	7.90	8.10	2.51	7.32	0.00	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	19.78	4.12	4.94	5.27	2.97	6.26	0.16	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.94	1.13	8.20	2.41	0.32	12.39	0.00	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	15.89	14.69	5.02	5.73	2.99	3.58	0.60	0.72
small intestine, fetal, donor1	10064-101I1	12.53	9.34	1.72	2.70	3.44	4.18	0.74	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3.08	1.03	0.00	0.00	0.00	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	43.42	19.13	6.46	11.63	4.91	7.75	1.03	1.81
somatostatinoma cell line:QGP-1	10781-110G7	3.22	0.80	0.80	0.00	0.27	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	159.90	187.65	111.49	62.40	119.75	16.06	20.65	7.34
spinal cord, adult, donor10252	10159-103A6	259.04	306.35	175.45	117.49	112.37	30.36	30.75	9.86
spinal cord, adult, donor10258	10369-105F9	174.33	91.32	134.21	80.25	155.65	6.23	8.99	7.61
spinal cord, fetal, donor1	10056-101H2	181.12	211.61	107.94	81.11	130.50	17.08	29.88	9.76
spinal cord, newborn, donor10223	10359-105E8	153.38	244.30	155.21	56.02	115.72	18.83	45.92	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.15	20.76	4.18	9.26	9.26	2.24	0.75	1.05
spleen, adult, pool1	10025-101D7	61.23	51.54	19.38	19.60	10.13	13.66	0.33	2.86
spleen, fetal, pool1	10044-101F8	66.35	60.86	21.06	24.71	15.57	17.00	1.67	4.13
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	10.77	1.66	1.55	2.28	0.31	4.04	0.10	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.52	3.99	5.70	2.28	1.52	11.96	0.00	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.56	18.52	10.13	9.44	6.29	10.13	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.94	9.77	14.46	4.69	6.25	9.77	0.78	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	4.61	1.01	4.28	0.79	0.45	4.28	0.00	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.10	6.35	4.66	2.54	2.54	9.32	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	65.15	29.19	8.88	19.04	8.88	8.46	0.42	0.85
stomach, fetal, donor1	10062-101H8	36.31	12.82	2.14	10.68	7.48	3.20	0.00	4.27
submaxillary gland, adult	10202-103F4	35.32	23.36	6.84	6.84	5.13	5.70	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	325.64	217.10	162.82	379.92	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	281.86	451.97	191.30	177.80	269.39	20.36	89.94	9.55
substantia nigra, adult, donor10258	10371-105G2	153.11	87.93	87.93	68.79	106.55	4.66	9.31	3.62
substantia nigra, newborn, donor10223	10358-105E7	73.48	204.91	77.02	29.68	125.06	17.66	20.49	10.60
synovial sarcoma cell line:HS-SY-II	10441-106E9	27.51	18.57	6.42	10.55	7.34	6.65	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	108.34	190.82	54.93	60.53	85.53	8.31	7.71	4.66
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	57.69	84.05	32.05	31.34	29.92	13.53	14.25	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	63.73	76.04	39.56	22.86	28.13	12.31	10.99	3.08
tenocyte, donor1	11763-123H8	30.72	17.11	4.54	11.52	7.33	1.75	0.35	0.00
tenocyte, donor2	11765-123I1	16.40	14.12	1.91	8.01	8.01	3.82	1.14	0.76
tenocyte, donor3	11768-123I4	19.65	8.90	1.11	7.78	2.59	1.48	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	38.75	11.56	14.79	12.41	5.27	19.72	0.17	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	12.79	3.70	5.09	2.16	0.92	11.25	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	59.20	22.94	18.75	17.36	10.07	16.27	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.58	7.11	6.22	7.24	2.41	10.03	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	2.27	11.35	1.89	0.76	12.48	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.36	6.33	10.03	5.45	2.40	5.34	0.44	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	3.58	1.95	4.89	0.65	0.98	9.77	0.00	0.33
testis, adult, pool1	10026-101D8	59.16	65.39	25.77	22.66	10.74	19.00	2.25	11.27
testis, adult, pool2	10096-102C6	48.27	47.82	35.64	23.91	11.28	22.10	2.26	15.34
thalamus - adult, donor10196	10168-103B6	189.89	198.72	113.71	88.32	147.93	6.62	27.60	3.31
thalamus, adult, donor10252	10154-103A1	331.63	494.01	210.83	200.67	256.77	28.60	89.55	13.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	170.90	73.90	44.65	69.28	130.87	3.08	15.40	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	79.38	93.21	23.88	38.70	50.89	3.62	8.56	4.78
thalamus, newborn, donor10223	10366-105F6	33.94	40.85	24.16	10.36	15.53	4.03	5.18	1.15
throat, adult	10209-103G2	81.89	39.20	11.24	21.47	13.23	4.24	1.00	1.50
throat, fetal, donor1	10061-101H7	52.71	39.92	12.19	15.84	13.71	8.23	0.61	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	20.67	5.17	0.99	7.15	4.97	1.99	0.20	0.00
thymus, adult, pool1	10027-101D9	38.97	32.21	5.77	13.12	6.16	7.65	0.50	1.79
thymus, fetal, pool1	10043-101F7	56.21	32.63	9.66	18.50	8.52	16.11	0.62	2.91
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.40	18.61	3.86	9.71	5.85	2.26	0.13	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	29.89	16.20	8.38	12.43	9.22	8.66	0.42	1.26
thyroid, adult, pool1	10028-101E1	48.34	24.35	7.00	14.56	4.39	6.72	0.56	1.96
thyroid, fetal, donor1	10060-101H6	37.70	24.26	2.64	9.76	5.01	5.54	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	27.72	15.40	15.40	27.72	18.48	0.00	0.00
tongue, adult	10203-103F5	72.80	44.19	7.68	18.61	16.05	5.81	1.40	2.79
tongue, fetal, donor1	10059-101H5	78.03	39.41	12.22	20.49	14.58	5.52	3.94	4.73
tonsil, adult, pool1	10047-101G2	38.57	21.04	7.51	10.62	5.31	9.22	0.30	1.10
trachea, adult, pool1	10029-101E2	41.06	30.35	9.65	13.01	5.97	8.43	0.65	2.78
trachea, fetal, donor1	10058-101H4	58.09	28.85	12.69	15.77	8.08	7.31	1.15	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.84	17.36	2.13	9.21	9.57	1.06	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	37.69	30.19	17.43	9.63	7.90	9.93	0.81	2.33
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.70	9.09	4.39	11.91	4.39	11.75	0.94	2.04
tridermal teratoma cell line:HGRT	10694-109G1	45.66	38.05	5.71	15.22	15.22	11.42	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.98	4.23	2.20	2.96	1.86	2.96	0.17	0.42
umbilical cord, fetal, donor1	10057-101H3	33.38	22.95	4.17	18.78	14.61	8.35	2.09	4.17
uterus, adult, pool1	10100-102D1	66.37	27.30	11.43	23.55	12.11	7.00	1.02	3.92
uterus, fetal, donor1	10055-101H1	45.56	31.74	8.19	13.82	7.17	6.66	1.54	0.51
vagina, adult	10204-103F6	106.62	65.91	25.20	28.43	15.51	15.51	4.52	7.11
vein, adult	10191-103E2	44.28	44.28	15.12	16.22	12.49	9.21	0.22	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.61	1.34	1.60	2.40	0.27	2.67	0.00	0.80